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1. Introduction 
____________________________________________________________________________ 
The cellular RNA levels are determined by RNA synthesis5, or transcription, RNA 
processing6 and RNA decay7,8. RNA synthesis rates regulate how much of the RNA is 
transcribed in a given system whereas, the rates of RNA decay control for how long the 
transcripts will be present in the system. All these steps are highly regulated and some are 
coupled to each other, kinetically or mechanistically9–11, providing substantial flexibility for 
gene expression adaptation to alterations in the environmental conditions.  
 The intermediate step, RNA processing, occurs co-transcriptionally12 and involves several 
biochemical steps necessary for the maturation of the primary transcripts. First, the 5’ methyl 
guanosine cap is added on the 5´ end of the precursor messenger (pre-mRNA)13. Second, most 
of the pre-mRNAs contain introns − sequences with no protein coding potential − that must be 
excised during mRNA maturation through a process called splicing14,15 (Box 1). Finally, once 
transcription through the gene is complete, the pre-mRNA is cleaved and  polyadenylated16 to 
generate its mature 3´end. The biogenesis of microRNA (miRNAs) (Box 2) is also part of a 
distinct RNA processing pathway. The sequence of the primary microRNA (pri-miRNA) 
promotes the formation of the secondary hairpin loop that is further processed to a mature 
miRNA17,18. The contribution of RNA processing in gene expression as well as the importance 
of the processing kinetics has only recently received attention due to the lack of proper tools for 
sufficient analysis. 
 Next-generation sequencing of total RNA (RNA-seq) allows to study the outcome of RNA 
processing at a given time point on a whole-transcriptome level19. Whole cell total RNA 
represents mostly the mature processed transcripts that are more stable and highly abundant, 
while the transcripts with high RNA decay rates are not detected. Therefore, detecting gene 
expression changes caused by treatment, virus infection or alterations in the environmental 
conditions using total RNA quantification can be misleading20. Furthermore, the majority of the 
sequencing reads in RNA-seq are associated with exons derived from highly expressed and 
stable transcripts, whereas only a small percentage of the sequencing reads cover intronic sites 
that are mostly associated with long and slowly processed introns21. Thus, steady-state RNA-seq 
alone provides incomplete information regarding the kinetics of RNA splicing and processing.  
To surmount the limitations of whole cell total RNA-seq, a diverse range of methods have 
been used to measure the kinetics of RNA processing.  In eukaryotic cells the RNA synthesis 
and processing are confined in distinct subcellular compartments. Thus, enriching for RNA 
molecules that are found in the cytoplasmic, nucleoplasmic and chromatin-associated 
compartments prior to RNA-seq, enables the analysis of distinct steps in the lifetime of 
individual RNA molecules22,23. Previous studies using cell fractionation methods showed that 
pre-mRNAs and pri-miRNAs are co-purified with salt, detergent and urea-resistant pellet, while 
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the soluble nuclear extract contains spliced and processed transcripts24–26. A study from our lab 
showed that endogenous Microprocessor activity can be determined using RNA sequencing18. 
Cellular fractionation protocol23 was used to isolate the nuclei and chromatin associated RNA 
enriching for the pri-miRNA transcripts. The Microprocessor cleavage signature was identified 
and the MicroProcessing Index (MPI) was defined as a measure for processing efficiency. The 
MPI is considering the expression levels of pri-miRNA that are reflected by the sequencing 
reads adjacent to the pre-miRNA and the read density of the precursor region. Significant 
depletion of read density at the pre-miRNA region generates negative MPI and corresponds to 
Box 1 | RNA splicing 
_____________________________________________________________________ 
The beginning and the end of an intron is marked by 5΄ and 3΄ splice junctions (SJs) that contain consensus 
sequences100. In metazoas the SJs consensus sequences are poorly conserved with 5΄ SJ GURAGU and a 3΄ SJ 
YAG where R is a purine and Y is a pyrimidine14. During splicing these points undergo “cutting and sewing” in a 
form of two transesterification reactions that are executed by a large ribonucleoprotein complex called 
spliceosome101.The SJs together with the branch point sequence (BPS; YNYURAY, N is any nucleotide) located 
18-40 nucleotides upstream of the 3΄ SJ are recognized in the premRNA by small nuclear ribonucleoproteins 
(snRNPs). U1, U2, U4/U6 and U5 snRNPs are forming the major spliceosome102. In vitro studies on pre-mRNA 
splicing identified a two-step transesterification reaction. The first transesterification step, known as branching, is 
held by a nucleophilic attack by the 2΄OH group of the adenosine found in the BPS on the guanine nucleotide at 
5΄SJ forming a branched RNA intermediate known as intron lariat. This results in a free 5΄ exon and an intron 
lariat-3΄ exon intermediate. In the second transesterification reaction the 3΄OH-group of the 3΄nucleotide end of 
the 5΄ exon attacks the phosphate group of the 3΄exon producing the ligated spliced mRNA and the excised intron 
lariat. During splicing the spliceosome is responsible for the folding of introns to favor the splicing reactions, the 
correct recognition and pairing of the splicing sites. Each snRNP consist of a snRNA (two in the case of U4/U6) 
and a variable number of specific proteins. Additionally, the U1, U2, U4 and U5 contain seven Sm proteins that 
together form an extremely stable Sm core of each snRNP103. Splicing is comprised by three reoccurring steps. 
First, the reactive groups on premRNA are recognized multiple times by trans-factors RNA or proteins to ensure 
the precision of the splicing reaction. Second, the RNA-RNA interactions and many functionally important 
interactions occurring within the spliceosome are mainly weak yet, are stabilized by a combination of multiple 
interactions that allows flexibility and dynamic regulation of splicing. Third, during the spliceosome assembly 
and later catalytic activation many RNP binding partners follow a stepwise mechanism of rearrangements. The 
first spliceosome assembly called complex E, starts from the U1 snRNP interaction with the 5΄ intron through 
base pairing interactions. Serine-arginine-rich (SR) proteins together with proteins of U1snRNP stabilize this 
step. In addition, SF1/BBP protein binds to the BPS while U2 auxiliary factor (U2AF) comprised by two subunits 
of 65 kDa (U2AF65) and 35 kDa (U2AF35) to the polypyrimidine track residing downstream of BPS. U2AF65 is 
in contact with SF1/BBP while U2AF35 binds the AG consensus of the 3΄SJ. The next step is the formation of 
complex A with U2snRNP binding to BPS through base pairing interactions. SF1/BBP binding with BPS and 
U2AF65 is hand over to the U2-associated protein p14 and SF3b155 respectively104. After A complex formation, 
U4/U6 and U5 snRNPs are recruited as preassembled tri-snRNP in a reaction catalyzed by DExD/H helicase 
Prp28 forming complex B. The spliceosome is still catalytically inactive and to become eligible to facilitate the 
first transesterification reaction U1 and U4 need to be destabilized or released from the complex. U6 snRNA is 
free to engage U2snRNA and the premRNA105,106. Several U4, U6 and U5 protein partners are also released 
through the activation process whereas the spliceosome complex B* undergoes the first catalytic step generating 
C complex that contains free exon 1 and the intron–exon 2 lariat intermediate. On this stage the 5΄SJ is positioned 
by U6snRNA through base pairing interactions with the conserved ACAGAG region of U6snRNA. The BSP is 
paired with the conserved sequence GUAGUA of U2snRNA. In addition, U5snRNA interacts with both of the 
exons and contributes to the positioning for the catalysis. Complex C undergoes additional ATP-dependent 
rearrangements before the second catalytic step107. The U2-speciﬁc SF3b14a/p14 protein and U5-specific Prp8 
protein are directly at or near the spliceosome’s active site and are important for the progression of the 
catalysis108. After the second catalytic step the spliceosome dissociates releasing U2, U5 and U6snRNPs to be 
recycled for other rounds of splicing and the mRNA is released. The release of the splice product from the 
spliceosome is catalyzed by the DExD/H helicase Prp22109 
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efficiently processed pri-miRNAs, whereas positive MPI values correspond to inefficiently 
processed pri-miRNAs. This study showed that the processing efficiency is highly variable 
among canonical pri-miRNAs and a major determinant for the expression levels of individual 
mature miRNAs. However, the processing efficiency of pri-miRNAs in steady-state chromatin-
associated RNA is not dependent on the expression level of the pri-miRNA. Several features, 
such as sequence-motifs around the precursor pre-miRNA hairpin in the pri-miRNA transcript 
and in the hairpin loop have been shown to be involved in processing efficiency in mammals. 
These sequence features include the UG at the position -14 and -13 at the basal stem, the GC(-
13) 13nt upstream of the pre-miRNA18, the apical loop GUG motifs and CNNC at the positions 
16 -1817.  The variations in pri-miRNA sequence composition are responsible for fine tuning 
miRNA expression levels. 
 RNA-seq analysis from chromatin bound-transcripts showed that many of them are 
accumulated on chromatin and are already processed. In addition, many ncRNAs such as 
snoRNAs and lncRNAs can be found in chromatin due to their role in transcription regulation 
and processing27. Hence, cell fractionation is a method to enrich chromatin-associated 
transcripts regardless of their age. While steady state chromatin-associated RNA sequencing 
approach provides insights into the average processing efficiency of steady-state pri-miRNA 
associated to chromatin, it cannot address the dynamics of this process.  
RNA labelling is another innovative biochemical method used to capture, isolate and 
follow the processing of the newly transcribed RNA in vivo. Nucleoside uridine analogs such as 
4-thiouridine (4sU)28,29, 5-ethylnyluridine (EU) and 5’bromo-uridine (BrU)30,31 are able to 
incorporate in to the newly transcribed RNA in living cells. These analogues can be added to the 
cell media enter the cell membrane and get incorporated into the pool of nucleotide phosphates 
Box 2 | miRNA biogenesis 
_________________________________________________________________________ 
MicroRNAs (miRNAs) are small non-coding RNAs in 22nt length long that act in the cytoplasm to direct post-
transcriptional repression. RNA pol II transcribes the primary miRNA (pri-mRNA); long transcripts that are also 
capped and polyadenylated. The sequence of the pri-miRNA promotes the formation of the secondary hairpin 
loop structure that is recognized by Microprocessor, a protein complex containing an RNaseIII enzyme Drosha 
and its cofactor DGCR8/pasha. Drosha recognizes the double-strand RNA-single-strand RNA junction formed at 
the hairpin base and serves as a ruler by measuring 11 bp from basal ssRNA-dsRNA junction110. Two DGR8 
proteins bind the stem and apical elements to ensure efficient and accurate processing110. Alternative cleavage of 
Drosha leads to the production of isomirs that differ in length and sequence111. The pre-miRNA product of the 
first-step cleavage is a hairpin of ~70nt nucleotides. The 2-nucleotide overhang of the hairpin at the 3´ end is 
recognized by Exportin 5 that transports the pre-miRNA hairpin to the cytoplasm. There, Dicer binds the pre-
miRNA hairpin through the 5´ phosphate, 3´ overhang and loop structure112.  Dicer also acts as a molecular ruler 
that cleaves pre-miRNAs yielding a mature- miRNA duplex with another typical 2 nt 3´ overhang. Alternative 
cleavage by Dicer may also leads to isomirs113. Finally, one strand of the mature miRNA, the “guide” strand 
RNA is loaded into AGO whereas the passenger strand is discarded. The strand RNA with the less stable 5´ end 
will become the guide RNA114.miRNAs recognize their mRNA targets via base-pair complementarity. The 
position 2-7nt of the mature miRNA is called the seed and is the most essential for target recognition115. The 
miRNA target sites are residing within the 3´ UTR of mRNAs that possess strong complementarity to the seed 
region. The AGO-miRNA binding to the target mRNA 3´UTR leads to gene silencing through translation 
repression and mRNA decay116 
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by means of the ribonucleoside salvage pathway32, and further get diffused into the nucleus 
(without going through additional transfection techniques such as electroporation or 
lipofection). After short pulse incubation the cells can be lysed, total RNA is extracted and 
depending on the uridine analog the labelled RNA can be isolated.  
4sU is rapidly taken up by cells and has minimal adverse effects on gene expression, RNA 
decay, protein stability and cell viability. The newly transcribed RNA (4sU-labelled RNA) is 
thiol-specifically biotinylated generating a disulphide bond with biotin and 4sU. The total RNA 
can be separated into labelled and unlabelled RNA with high purity using streptavidin-coated 
magnetic beads. A reducing reagent is then added to the beads to cleave the disulphide bond 
releasing the newly transcribed RNA. 4sU is a labelling analogue used efficiently in many 
studies however, it has been shown that prolonged incubation with 4sU reduced cell growth33. 
EU is similarly incorporated into the nascent RNA and the EU-labelled RNA is separated from 
total RNA by biotinylating of EU in copper-catalysed cycloaddition reaction (often referred to 
as click chemistry) followed by purification on streptavidin magnetic beads. However, 
prolonged incubation of cells with 4sU or EU causes inhibition of cell growth. BrU on the other 
hand, does not cause harmful effects compared to the rest uridine analogues34. BrU is 
incorporated into the cells, converted to BrUTP; similar to 4sUTP, and the nascent RNA is 
labeled by BrU. The BrU-labelled RNA can be isolated using anti-Bromodeoxyuridine (BrdU) 
antibody via simple immunoprecipitation. The BrU-RNAs do not cause misincorporation by 
reverse transcriptase and can be used as templates for further quantitative analysis and deep 
sequencing35. Additionally, in order to study the RNA splicing after the BrU-pulse the BrU can 
be removed with several washes and replaced with excess of uridine containing media. Then 
cells can be lysed at different time points and RNA splicing can be followed by analyzing the 
sequencing reads across the borders of exons and introns36. The analysis can provide 
information regarding RNA transcription and any RNA processing that took place during the  
Figure 1: Schematic representation depicting features contributing to RNA splicing kinetics. 
Distance from TSS and TES, Intron length, SJ score, GC content, ESEs ESSs, and synthesis rates.  
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labelling period. Moreover, incorporating the chasing time points in to the analysis, allows to 
study the fate of the nascent RNA over time and RNA processing30. 
The combination of ultra-short and progressive 4sU labelling time points starting from 5 
minutes to 60 minutes allowed to study the kinetics of RNA processing, in particular RNA 
splicing and alternative splicing (Box 3)36,37. In particular, this method enabled the identification 
of distinct intron classes with different splicing kinetics. Interestingly, each intron class of 
distinct splicing kinetics was characterised by specific intron length, gene length, splice site 
strength, distance from transcription start site, distance from transcription end site, presence of 
ESEs and/or ESSs, synthesis rates, and GC content (Figure 1). The fast-spliced introns were 
mostly characterised by low GC content, strong splice sites score, higher distance from TSS and 
TES, high levels of ESEs and low levels of  ESSs in their upstream and downstream exons36. 
The slow processed introns show higher synthesis rates, have longer sequence and have a higher 
probability to be alternative spliced36.  
The dynamic interactions of the splicing regulatory factors with the spliceosome ultimately 
regulate the decision of constitutive or alternative splicing38,39. However, since splicing of most 
introns occurs co-transcriptionally9–11,40, factors that regulate transcription also affect constitutive 
and  alternative splicing41. The regulation of splicing and the final splicing product derives from 
a combination of RNA Binding Proteins (RBPs) presence, recruitment to their underlying 
sequence and the interactive environment. Direct competition or cooperative recruitments of 
RBPs as well as modulations of the RNA local secondary structure are means of interactions that 
govern the splicing regulation. Altogether, the information in the pre-mRNA sequence and how 
it is interpreted by RBPs is ruled by the so-called “splicing code”. Deciphering the splicing code 
Box 3 | Alternative splicing 
__________________________________________________________________________ 
Studies using RNA-seq discovered numerous alternative isoforms of mammalian transcripts indicating that 
most multi-exon genes are alternatively spliced 117. Alternative splicing allows the production of more than one 
unique mRNA from a single gene117. mRNAs generated from alternative splicing could differ in their UTRs 
and/or coding sequence. Events such as, exon skipping (removal of specific exons), exon inclusion (a choice 
between mutually exclusive exons), the choice of alternative splice sites and intron retention contribute to the 
final outcome of transcript diversity as well as protein complexity. Nearly 95% of human genes have been 
estimated to undergo alternative splicing19 and approximately 37% 118 of the ~ 20,000 human protein-coding 
genes produce multiple protein isoforms. The spliceosome is capable to catalyze both constitutive and alternative 
splicing reactions and the decision is controlled mainly from the spliceosome assembly on the pre-mRNA. 
Human introns are on average ~5kb in length and contain many sequences that resemble the authentic consensus 
splice sites. However, the pseudo-exons are rarely spliced suggesting that the exon- intron definition is not only 
defined by the main consensus splicing sequences but also from other additional splicing regulatory elements 
(SREs)119. According to the location and function the SREs are classified as exonic splicing enhancers (ESEs), 
intronic splicing enhancers (ISEs), exonic splicing silencers (ESSs) or intronic splicing silencers (ISSs). Trans-
acting protein splicing factors are recruited to the SREs and promote or hinder different steps during splicing 
reaction such as early and intermediate steps of the spliceosome assembly120. Constitutive spliced exons are 
enriched in ESEs that recruit members of the as Ser/Arg-rich (SR) protein family each of which facilitate the 
spliceosome assembly. More specifically, SR proteins interact with ESEs to form a barrier and to ensure the 
correct recognition of 5’ and 3’ order preventing prevents exon skipping121. On the other hand, various 
heterogeneous nuclear ribonucleoproteins (hnRNPs) typically recognize ESSs and inhibit splicing. In both cases 
U2 and U1 snRNPs are affected from SRs or hnRNPs presence. The activity of SRs and hnRNPs is context 
specific since SRs could also inhibit splicing when are bound to ISS and similarly hnRNPs can promote splicing 
when are bound to ISEs122. In addition, these two protein families exhibit antagonistic effects on splice site 
recognition with a well characterized example SR protein ASF/SF2 and hnRNP A1123  
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is a necessary step to tackle the biological complexity of the splicing regulation and the splicing-
caused diseases. This PhD thesis conducted extended research to investigate the role of N6-
Methyladenosine (m6A), an RNA modification involved in many RNA processes42–48, in splicing 
kinetics.  
 
 Insights into m6A RNA methylation 
_______________________________________________________ 
All major biological macromolecules including DNA, RNA, proteins and lipids are being 
subjected to enzyme-catalyzed covalent modifications, following their synthesis, that are 
important for their structure, function and stability49. Modified nucleotides in RNA have been 
studied since the 1960s with N6-Methyladenosine (m6A)1, 5-methylcytidine (m5C)2, and 
pseudouridine (Ψ)3 to be the first identified in rRNAs, tRNAs and snRNAs. To date, more than 
100 distinct RNA modifications have been identified within each of the four RNA 
nucleosides50. The multitude of  RNA modifications constitute the 'Epitranscriptome'45 and our 
understanding of this additional regulatory layer of biology resting between DNA and proteins, 
is still in its infancy. 
m6A is a methylation on the nitrogen 6 position of adenosine and is the most abundant 
internal mRNA modification43,45,51. It is deposited by methyltransferase complex with 
methyltransferase-like 3 (METTL3)52 as the main catalytical domain and can be removed by 
demethylases such as the Fat mass and obesity-associated (FTO)53 and AlkB homolog 5 
(ALKBH5)54 (Box 4). Since the early 70s m6A has been estimated to be one per 700-800 
nucleotides and is deposited preferentially within G (m6A) C or A (m6A) C sequence motifs55. 
However, only a portion of these motifs in the transcriptome bear detectable methylation55,56. 
The development of N6-methyladenosine–sequencing (see m6A-Seq) encouraged transcriptome 
wide m6A-mapping studies on the mRNA and/or total RNA level extracted from different 
organisms and tissues. These studies located m6A in at least 8,000 transcripts with a consistent 
m6A peak distribution on coding sequences in long exons, in the 5´UTRs and near stop 
codons43,51 . 
m6A can alter the RNA structure modulating the accessibility of RNA binding factors to 
their RNA sequence57. Although m6A does not change the hydrogen-bonding donors and 
acceptors on the base, the energetics of A•U pair are affected. N6-Methyladenosine in solution 
exists in two isomeric forms, in syn-orientation and in anti-orientation with a preference in syn 
orientation (Figure 2). In the syn-orientation the methyl group is located on the N1 side of the 
base and disrupts Watson-Crick base pairing. In the anti-orientation form the methyl group is on 
the N7 side of the base and the Watson-Crick base pairing is unhindered. However, the anti-
conformation elicits an energetic penalty due to the steric clash between the methyl group and 
N7 that leads to destabilization of m6A•U pairs in comparison to A•U pairs (Figure 2). 
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Thermodynamic measurements revealed that m6A found in duplexes causes a destabilization of 
0.5–1.7 kcal/mol. However, m6A in unpaired positions stacks more strongly than A stabilizing 
the single stranded locations58. In agreement, cellular RNAs show decreased base pairing 
around m6A sites as well as structural transition from paired to unpaired in the proximity of 
m6A modifications 
Figure 2: Conformation and structure of m6A in RNA. 
 (A) Syn methyl orientation is favored over anti when the base is unpaired due to the 
unfavoured steric clash between the methyl group and N7. (B) Multiple pairing configurations 
are possible for m6A paired opposite U. The anti/anti structure has been found in an RNA 
duplex; the methyl group is spring-loaded into the high-energy anti conformation, trapped there 
by pairing with U and surrounding duplex structure. The green highlighted structure is the 
favoured and found structure 58 
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 Box 4 | m6A writers and erasers 
_____________________________________________________________________ 
Early studies discovered a large protein complex responsible for m6A methylation that is comprised by 
three components of 30, 200, 875 kDa124. Further analysis revealed that the 200-kDa component contains the S-
adenosylmethionine-binding site on a 70-kDa subunit (The catalytic component was detected by its ability to 
crosslink to [3H]-SAM).  S-adenosynlmethionine (SAM), the enzymatic cofactor that participates in most of the 
methylation reactions in the cell. The 70-kDa subunit called MT-A70 or METTL3 is able to catalyze the transfer 
of a methyl group from the donor substrate S-adenosyl methionine (SAM) to the adenine nucleobases in acceptor 
RNA substrates124. Phylogenetic analysis of METTL3 family identified that METTL14 shares 43% identity with 
METTL3 and is highly conserved in mammals52. Crystal structures of METTL3/METTL14 as the ability to 
methylate RNA substrates125. The interaction of METTL14 with METTL3 complex revealed that METTL14 
mainly functions as a structural scaffold and only METTL3 results in substantial higher methyltransferase 
activity than METTL3 alone. Proteome wide interaction analysis showed METTL14 and METTL3 form a 
complex that is regulated by the association of a WTAP, a pre-mRNA splicing regulator52. WTAP does not have 
a methyltransferase activity however, its presence is necessary for the localization of METTL3 and METTL14 in 
the nuclear speckles. Depletion of WTAP leads to substantial loss of m6A formation on mRNA51. 
Immunoprecipitation-mass spectrometry (IP-MS) was used to identify KIAA1429 (also known as vir-like m6A 
methyltransferase associated or VIRMA) an additional interaction partner of methyltransferase complex that is 
important to mediate the full activity of the complex51. Depletion of  KIAA1429 causes loss of m6A in human 
cell lines as well as Drosophila S2R+ cells51,71.RBM15 and its paralog RBM15B are two additional components 
of the methyltransferase complex. Both of the proteins interact with METTL3 in a WTAP dependent manner and 
knockdown experiments showed a significant reduction of m6A on mRNA level. These findings were also 
supported by studies in Drosophila where a homolog of RBM15, Spenito (Nito) is shown to be important for the 
m6A deposition in flies71,72. METTL16 is the only methyltransferase identified to methylate mRNAs encoding 
the SAM-synthetase MAT2A at 3´UTR. When the SAM cellular levels are depleted MAT2A mRNA is 
stabilized. METTL16 has been suggested to control mRNA stability of MAT2A and the SAM depended MAT2A 
expression96. The vertebrate conserved hairpin (hp1) loop structure found in the 3´UTR of MAT2A mRNA is the 
substrate for the METTL16. Under high concentrations of SAM METTL16 is able to methylate MAT2A mRNA 
leading to its degradation. Fine tuning MAT2A expression through m6A modification may contribute to the 
flexibility and precision of SAM-depended processes. According to the human protein atlas all the five proteins 
are expressed in all the human tissues126. An important finding was the identification of m6A demethylases that 
could be endogenously expressed. Fat-mass and obesity-associated protein (FTO) belongs to the non-heme 
Fe(II)- and α-KG-dependent dioxygenase AlkB family proteins and can catalyse the Fe(II)- and 2OG-dependent 
demethylation of 3-methylthymine in single-stranded DNA, with concomitant production of succinate, 
formaldehyde, and carbon dioxide127. Subsequent studies showed that FTO could also demethylate 3-
methyluracil (3mU) in single stranded RNAs that can be found on rRNAs128. Further in vitro studies identified 
FTO demethylation activity can also be applied on m6A residues in RNA. In fact, FTO oxidize N6-
methyladenosine to generate N6-hydroxymethyladenosine as an intermediate modification, and N6-
formyladenosine as a further oxidized product oxidize. These two chemical products have ~3h half-life times in 
aqueous solution under physiological conditions and are found in human cells and mouse tissues129. 
Overexpression of FTO in Hela cells reduced m6A levels on polyA enriched RNA  to ~18% whereas FTO 
knockdown increased m6A levels to ~23%53. FTO is localized in the nucleus and cytoplasm and according to 
FTO-iCLIP data FTO targets are mostly intronic regions with no specificity for the m6A sequence motif 42. FTO 
is highly expressed in the brain and widely expressed in all adult and fetal tissues130 . Soon after FTO discovery a 
second mammalian demethylase was identified from the same protein family, called α‑ketoglutarate‑dependent 
dioxygenase alkB homologue 5 (ALKBH5). Both in vitro and in vivo ALKBH5 has the ability to catalyze the 
removal of the m6A modification on nuclear RNA29. ALKBH5 demethylates preferentially single stranded 
substrates DNA or RNA and similar to FTO, is able to recognize m6A modification on non-consensus sites 30. 
ALKBH5 is enriched in the nucleus, is predominately expressed in testis and has relatively low expression levels 
in other tissues54. Knock down experiments increased m6A levels on mRNA by ~9% whereas ~50-fold 
overexpression of ALKBH5 lead to ~29% of m6A level reduction. The subtle changes on m6A level, similarly to 
FTO, indicate that both demethylases target specific m6A residues on mRNA level. m6A has been characterized 
as a “conformational marker” that regulates the conformational changes of the modified RNA that serves as the 
substrate for the demethylases. Thus m6A its self in different sequence environment profoundly impacts the 
interaction with m6A –recognizing proteins such as ALKBH5 and FTO131. 
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m6A readers mediating m6A function in RNA processing 
____________________________________________________________ 
 The protein factors that mediate the outcomes of m6A on RNAs are important to 
understand the biological role of m6A. m6A modification can be “read” in different forms such 
as by direct recognition from a binding pocket of YTH-domain proteins 59 or indirect 
recognition through a structural change that is caused by the modification57.  In addition, 
hydrophobic modifications such as m6A induce solvation penalty in water and their interaction 
to hydrophobic protein side-chain residues can reduce the solvation penalty (Figure 3). SFSF 
and HNRNP proteins have no modification-specific binding domain however; they selectively 
bind adjacent to m6A residues60.   
The YTH domain is comprised ~ 145 amino acids that fold in to a distinct module with an 
aromatic cage of three tryptophan residues engaging the methyl group of m6A. The aromatic 
rings of the two of the three Trps that bind two m6A are almost parallel to each other where 
m6A adenine moiety is sandwiched by them. Mutations of the aromatic cage residues reduce 
significantly the binding of YTH-domain proteins to m6A RNA probes in vitro60.    
Initial in-vitro pulldown experiments with m6A modified RNA baits identified the 
YTHDF2 and YTHDF3 as m6A binding proteins61.  YTH domain proteins can be divided based 
on their sequence to three major classes DC1; DC2 and the DF family comprising nearly three 
identical paralogs DF1, DF2 and DF3. The three DF proteins and DC2 are primarily 
cytoplasmic while DC1 is located in the nucleus62,63. DF proteins have similar structure and 
contain two domains; a C-terminally located YTH domain and a large low-complexity domain 
containing Glutamine (Q), Asparagine (N) and Proline (P) residues. Low–complexity domains 
are regions of protein sequences with biased amino acid composition, flexible enough to bind 
several different targets64. On the other hand, DC1 contains an YTH domain and multiple 
Figure 3: m6A interaction with m6A readers 
(A) m6A readers such as YTH-domain proteins bind to the m6A directly and selectively lead the 
transcripts to distinct RNA pathways. (B) m6A alters the secondary structure of mRNA, exposing or 
masking potential RNA-binding motifs. (C) m6A introduces a hydrophobic chemical group. The 
hydrophobic amino acid chains or low complexity regions of proteins associate with m6A and reduce the 
solvation penalty. 
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nuclear localization elements and an SH2 domain. YTHDC2 is an RNA-induced ATPase with a 
3΄ to 5΄ RNA helicase activity and it  is found in the nucleus and in the cytoplasm65.   
In the cytosol, YTHDF1 and YTHDF3 act cooperatively to promote ribosome loading of 
their m6A methylated mRNA targets66,67. More specifically YTHDF1 interacts with ribosomal 
subunits and translation initiation factors complex 3 (elF3) promoting translations of YTHDF1 
bound transcripts66. On the other hand, YTHDF2 decreases the mRNA stability of its m6A 
mRNA targets and promotes degradation by recruiting CCR4-NOT deadenylase complex68. 
Over all the YTHDFs proteins have more than 50% common m6A mRNA targets and can 
interact with each other with an RNA independent manner. YTHDF3 seems to interact first with 
m6A mRNA targets and functions as a hub for partitioning its common targets with YTHDF1 
and YTHDF2. YTHDF3 might contribute to RNA specificity while YTHDF1 and YTHDF2 
contribute to RNA binding affinity. In this way the targeted methylated transcripts have 
enhanced translation efficiency and a fast degradation rate in a highly regulated environment 
controlled by the YTHDF proteins67.  
The nuclear m6A reader YTHDC1 promotes exon inclusion in targeted mRNAs through 
the recruitment of the splicing factor SRSF3. In the meantime, SRSF10, another splicing factor 
that promotes the opposite effect, exon exclusion, is competed away by the YTHDC1/SRSF3 
complex. Additionally, YTHDC1 promotes SRSF3 localization to the nuclear speckles while 
repelling SRSF10. Thus, m6A and the stoichiometry of YTHDC1/SRSF3 and SRSF10 regulate 
the final outcome of  their target mRNAs69. Independently from its role in splicing, YTHDC1 
mediates export of methylated mRNA from nucleus to the cytoplasm through SRSF3 and the 
nuclear mRNA export receptor (NXF1). SRSF3 has a lack of biochemical selectivity for m6A in 
vitro yet, its interaction with YTHDC1 and NXF1 couple’s m6A selectivity to in nuclear 
export70. In Drosophila, YT521-B the homologue of YTHDC1, regulates many splicing events 
of targeted methylated transcripts. More specifically, YT521-B binds to m6A residues in the 
Sex lethal mRNA and regulates sex determination by repressing the inclusion of the male-
specific exon of the transcript71. YTHDC1 also, promotes the epigenetic silencing effects of 
XIST, a non-coding RNA important for the silencing of genes on one X chromosome in female 
cells72. XIST m6A residues are essential for the gene silencing effect on X chromosome through 
YTHDC1 that interacts with multiple epigenetic regulators72. YTHDC2 m6A reader is essential 
for male and female fertility in mice for maintaining transcripts essential for early meiotic 
progression37. Furthermore, YTHDC2 enhances the translation efficiency and mRNA 
degradation of its targeted methylated transcripts 42. In addition, YTHDC2 was found to recruit 
the 5ʹ to 3ʹ exoribonuclease XRN1 suggesting a mechanism to destabilize its mRNA targets73.   
Heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNPA2B1) is a nuclear reader of 
m6A and binds to RGm6AC sites on nuclear RNAs in vivo and in vitro74. HNRNPA2B1 
regulates alternative splicing of exons in a set of transcripts in a similar manner as METTL374. 
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In addition, HNRNPA2B1 is responsible for the nuclear processing of a subset of miRNAs 
whose maturation is dependent on METTL3 activity74. More specifically, depletion of 
HNRNPA2B1 or METTL3 leads to accumulation of pri-miRNA transcripts in the nucleus. 
HNRNPA2B1 recognizes and binds methylated pri-miRNA transcripts interacts with DGCR8 
by protein-protein interaction and facilitates their processing74.  
Heterogeneous nuclear ribonucleoprotein C (HNRNPC) protein is a member of a large 
ubiquitously expressed family that bind nascent RNA transcripts affecting pre-mRNA stability, 
splicing, nuclear export and translation. HNRNPC preferentially binds single stranded U-tracks 
(five or more contiguous uridines). M6A modification found within 50 residues away of 
HNRNPC binding site can alter the local RNA structure enhancing the accessibility of 
HNRNPC binding. The mechanism where m6A regulates the binding of RNA binding proteins 
via structural changes is called m6A-switch57. Most of the m6A switches for HNRNPC protein 
are found within intron regions of coding and non-coding RNAs. In coding RNAs the m6A-
switches are located within long exons near stop codons and in the 3’UTR, following m6A 
known topology of mRNA. The gene expression of more than five thousand genes is co-
regulated by the methyltransferase complex and HNRNPC. Furthermore, the splicing of more 
than 200 genes with multiple m6A-switched sites is co regulated from the methyltransferase 
complex and HNRNPC57.  
Heterogeneous nuclear ribonucleoprotein G (HNRNPG) is another m6A reader that uses a 
low-complexity region to recognize an RNA binding motif exposed by m6A modification75. 
The RNA binding motif of HNRNPG is a purine rich region that overlaps with the m6A 
consensus sequence. More than thirteen thousand m6A sites are bound by HNRNPG with more 
than fifty per cent residing in introns. Knock down experiments of HNRNPG and METTL3 or 
METTL14 led to similar gene expression changes as well as alternative splicing events75.  
m6A detection and mapping methods 
_____________________________________________________________________________ 
The first method used to detect base modifications was a combination of chemical or 
enzymatic digestion, radiolabeling and thin-layer chromatography76. Later, this method evolved 
into liquid chromatography coupled to mass spectrometry (LC-MS/MS), that nowadays is used 
to identify RNA modifications and to determine their global abundance77. LC-MS/MS is an 
extremely sensitive and accurate tool able to determine the amount of RNA modifications in the 
range of femtomole. To obtain such high sensitivity it is necessary to relate the sample signals 
with absolute amount of the modification such as spike-in measurements, or internal standards. 
Dynamic multiple reaction monitoring (DMRM) and neutral loss scan (NLS) are the two mainly 
modes used in LC-MS/MS77. DMRM method can be performed by a triple quadrupole mass 
analyzer where multiple precursor ions are chosen by adjusted mass-to-charge ratios and 
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fragmented in the collision cell. The ion products are then detected and the corresponding 
modified nucleosides are rendered in a mass spectrum. DMRM has reduced chemical 
background and it allows the quantification of different nucleosides at the same time. NLS 
allows the analysis of novel modified nucleosides however, the sensitivity is lower than DMRM 
method. The main disadvantage of LC-MS/MS is the inability to provide sequence-level 
information since the RNA is digested into single nucleotides or nucleosides which are then 
subjected for further analysis. 
To gain more information regarding the location of m6A sites, m6A-Seq is applied using 
RNA purified from various tissues or cell lines43,45. Total RNA or mRNA is chemically 
fragmented into ~100nt length and used as input for immunoprecipitation using an anti-m6A 
affinity purified antibody. The methylated RNA fragments are enriched over the randomly 
fragmented transcriptome and subjected to high-throughput sequencing to determine the identity 
of the methylated fragments. The randomly fragmented input is also sequenced and the m6A 
sites are identified using a peak-detection algorithm that finds the relative enrichment of 
methylated fragments over input. m6A-Seq identifies 200nt regions in the transcriptome were 
m6A site could be found. The peak summit is assumed to be in close proximity with the actual 
methylated site43. The limiting factor of m6A-Seq is the resolution since it does not provide 
single nucleotide information. In order to increase the resolution level and at the same time 
validate the m6A sites de novo motif search is applied. m6A motif should have a positional 
enrichment near the m6A peak summits over negative peak regions which are randomly 
generated genomic intervals. Nevertheless, single nucleotide resolution methods can be used for 
higher resolution on the m6A sites. 
Site-specific cleavage and radioactive-labeling followed by ligation-assisted extraction and 
thin-layer chromatography (SCARLET) determines the exact location of the m6A residue and 
its modification fraction in single nucleotide resolution for a specific mRNA or long ncRNA78. 
The method starts from total RNA or mRNA isolation and RNase H cleavage guided by a 
complementary 2′-OMe/2′-H chimeric oligonucleotide leading to site specific cleavage 5΄ to the 
candidate site. The point of digestion is radiolabeled with 32P and the 32P-labeled RNA fragment 
is splint-ligated to a 116-nucleotide single-stranded DNA oligonucleotide using DNA ligase78. 
RNAseTI/A treatment is used to completely digest all the RNA, whereas the 32P-labeled 
candidate fragment remains intact. The DNA-32P-labeled candidate is analysed on a denaturing 
gel, excised and digested with nuclease P1 to produce mononucleotides containing 5′ phosphate. 
Finally, thin-layer chromatography is applied to determine the m6A modification status.  
m6A individual-nucleotide-resolution crosslinking and immunoprecipitation (miCLIP) is a 
method that enables single nucleotide resolution mapping of m6A on a transcriptome scale79. 
miCLIP is based on the property of certain m6A antibodies to crosslinked to m6A containing 
RNA fragments and cause a reverse transcriptase-induced mutation or truncation. miCLIP 
17
follows the same steps as m6A Seq with an intermediated step of UV crosslink after the 
addition of the m6A antibody. After the elution a proteinase K treatment is followed and the 
m6A RNA fragments are subjected for sequencing. Finally, the mutation sites or C to T 
transitions at position +1 relative to A detected by sequencing are used to find where m6A 
residues are located in the transcriptome after bioinformatic analysis79.  
All the above-mentioned methods to identify m6A lack stoichiometry information and are 
insensitive to the proportion of methylated transcript or sites. m6A-level and isoform-
characterization sequencing (m6A-LAIC-seq80) is a quantitative approach for assessing the 
methylation status on a whole-transcriptome scale. Total RNA or mRNA is subjected to 
immunoprecipitation without prior fragmentation. The eluted methylated transcripts together 
with the supernatant non-methylated transcripts are separated. External RNA Controls 
Consortium (ERCC) spike ins are added to each fraction before sequencing. The m6A levels of 
a gene can be quantified using the ERCC-normalizes RNA abundances in different pools. 
 
 
 
 
 
 
 
 
 
 
 
 Aim 1 | Studying pri-miRNA processing kinetics 
_____________________________________________________________________ 
To address the dynamics of the pri-miRNA processing we established a pulse-chase approach 
that allow us to capture an earlier RNA processing stage than chromatin-associated RNA and 
followed its processing during a 1-h chase. With this we were able to study the pri-miRNAs 
processing kinetics in high resolution through time. Partial results of the presented work have 
been published in3,4 
 
Aim 2 | Nascent m6A role in splicing kinetics 
__________________________________________________________________________ 
In order to expand “the splicing code” and study the role of m6A in splicing kinetics we needed 
to use a technic that could identify m6A deposition on nascent RNA. All the existing technics 
mentioned above are not able to capture nascent RNA or to identify the nascent m6A 
deposition. Thus, two novel techniques have been developed to capture the nascent m6A 
deposition and at the same time follow the RNA processing kinetics. Partial results of the 
presented work have been published in2. 
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2. Materials and Methods 
______________________________________________________________________ 
Lab Equipment 
______________________________________________________________________ 
Cell culture dish 100 x 20mm, 150 x 25mm 
Laminar flow hood 
Cell culture incubator 
Refrigerated microcentrifuge 
1.5 ml Protein LoBind tubes 
1.5 ml DNA Lobind tubes 
5ml Eppendorf tubes 
Refrigerated Eppendorf 1.5 ml shaker 
Agilent 2100 Bioanalyzer  
Qybit ® Fluorometer 
Dynal magnetic separation rack 
Tube Rotator 
Illumina HiSeq 2500 
_____________________________________________________________________________ 
 Chemicals     Supplier, catalog number 
_____________________________________________________________________________ 
Opti-MEMTM I Reduced Serum Medium  Thermo Fisher Scientific, 31985062 
 (-)-5-Bromouridine    Santa Cruz Biotechnology, CAS 957-75-5 
Uridine      Sigma-Aldrich, U3750-25G 
 anti-BrU purified     BD Pharmingen, 555627 
TRIzol Reagent     Thermo Fisher Scientific, 5596-01 
GlycoBlue™      Thermo Fisher Scientific, AM9515 
Tris-HCl, pH 7.5    Alfa Aesal, N25B905 
Igepal CA-6300     Sigma-Aldrich, I8896-100ML 
BSA, acetylated (20 mg/mL)   Thermo Fisher Scientific, AM2614 
Ethanol      Merck, 1.009.832.500 
3M sodium acetate (pH 5.2)   Thermo Fisher Scientific, AM9740 
SUPERase• In™ RNase Inhibitor  Thermo Fisher Scientific, AM2696 
PBS, pH 7.4      Thermo Fisher Scientific, 10010056 
anti-m6A polyclonal antibody   Synaptic Systems, 202 003 
N6-methyl-ATP    TriLink, N-1013 
C11H15N5O7PNa    Sigma-Aldrich, M2780 
Chroroform      Merck, 1.02445.2500 
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Isoamyl alcohol    Serva, 39557.02 
Isopropanol      Merck, 1.09634.2500 
DMEM,     Thermo Fisher Scientific, 11965092 
Fetal Bovine Serum     Thermo Fisher Scientific, 10500064 
Protein G/A Dynabeads    Thermo Fisher Scientific, 10004D/ 10002D 
Distilled water      Thermo Fisher Scientific, 10977049 
EDTA pH 8,0 (0,5 M)    AppliChem GmbH, A3145,1000 
NaCl      Sigma-Aldrich, S3014-1KG 
ZnCl2      Sigma-Aldrich, 96468 
anti-METTL3 Polyclonal antibody  Proteintech, 15073-1-AP 
ERCC RNA Spike-In Mix   Thermo Fisher Scientific, 4456740 
_____________________________________________________________________________ 
Kits      Supplier, catalog number 
_____________________________________________________________________________ 
GoScript Reverse Transcriptase   Promega, A5003 
GoTaq qPCR Master mix   Promega, A6001 
Qubit® RNA HS Assay Kit   Thermo Fisher Scientific, Q32852 
Agilent RNA 6000 Pico kit    Agilent, 5067-1513 
HiPerFect Transfection Reagent   Qiagen, 301704 
T7 RNA Polymerase    Thermo Fisher Scientific, 18033019 
TruSeq Stranded mRNA Library Preparation Illumina, 20020594 
SuperSignal West DURA Extended Duration Thermo Fisher Scientific, 10445345  
____________________________________________________________________________ 
SiRNAs      Integrated Device Technology, Inc. (IDT)  
____________________________________________________________________________ 
NAME siRNA Target Sequence 5’→3’ 
Mettl3-1 5’-ACUGCUCUUUCCUUAAUA 
5’-AAACAUGUAUUAAGGAAA 
Mettl3-2 5’-CCAACAGUCCACUAAGGA 
5’-CUGUUGUUCCUUAGUGGA 
Mettl3-3 5’-AGGCAAGGAACAAUCCAU 
5’-UUCAACAAUGGAUUGUUC 
Mettl3-4 5’-AGCCAAGGAACAAUCCAU 
5’-UUCAACAAUGGAUUGUUC 
Control NCI IDT controls 
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Methods: 
_______________________________________________________________________ 
 
“Cell culture and BrU-chase Seq. 
HEK293 cells were cultured in DMEM growth-medium supplemented with 10% Fetal Bovine 
Serum (FBS) under normal growth conditions (37°C and 5% CO2). The day before bromouridine 
(BrU) labelling ~2.0 x 10^6 cells were seeded in 100 mm plates with 10ml media, one plate for 
each time point. Cells were 70-80% confluent before the addition bromouridine (BrU). BrU (-5-
Bromouridine cat.no. CAS 957-75-5 Santa Cruz Biotechnology) was added to a final 
concentration of 2 mM to the media and cells were incubated at normal growth conditions for 15 
minutes (pulse). Cells were washed thrice in PBS and either collected directly (0 minutes chase 
time point) or chased in conditional media supplemented with 20 mM uridine (Sigma cat.no 
U3750-25G) for 15, 30 and 60 minutes. RNA was purified using TRIzol following manufacturer’s 
instructions. In this step we followed the protocol of (Paulsen et al., 2013) with some 
modifications. 35ul of anti of anti-mouse IgG magnetic Dynabeads (Invitrogen) were transferred 
to a 1.5ml microfuge Protein Low binding tube and washed 3 times with BrU-IP 1X buffer (0.1% 
BSA in RNAse free PBS). After the final wash, the beads were resuspended with BrU-IP 1X 
buffer supplemented with SUPERase• In™ RNase Inhibitor 1:2000 together with BrdU antibody 
(5μg of antibody per 100 μg RNA). Antibody-beads mixture was incubated for 1hour at room 
temperature with gentle rotation following 3 washes with 1X BrU-IP. 150 μg RNA was used for 
each BrU-IP and heated up for 4 minutes at 65°C prior to IP. The same amount of unlabeled total 
RNA was used as a negative control. 5X BrU-IP (0.5% BSA 5X PBS supplemented with 
SUPERase• In™ RNase Inhibitor 1:2000) was added to the RNA to have a final concertation of 
1X. RNA-antibody-beads mixture was incubated for 90 minutes at room temperature with gentle 
rotation in a final volume of 800 μl. The beads were washed thrice with 800 μl 1X BrU-IP at room 
temperature. For all wash steps, with the exception of the elution step, the beads were washed for 
5 min rotating then placed on a magnetic rack and the wash buffers were discarded.  At the last 
wash the Protein low binding tubes were replaced with DNA LoBind tubes.  For elution 200 μl 
of Elution buffer (0.1% BSA and 25 mM bromouridine in PBS) were added directly on the beads 
and the tubes were incubated for 60 minutes with continuous shaking (1100 rpm) at 4 °C. The 
supernatant (eluate w/o beads) was transferred to a new tube and RNA was precipitated by adding 
1/10 volumes of 3M sodium acetate (pH 5.2) and 3-4 volumes of 100% ethanol. RNA was allowed 
to precipitate at −80 °C overnight. RNA pellet was washed twice with 75% ethanol and 
resuspended in RNase-free water. RNA quality was analyzed using Agilent 2100 Bioanalyzer 
with an Agilent RNA 6000 Pico kit according to the manufacturer’s instructions.  
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Filtering and annotation of miRNAs 
microRNAs used in the analysis were filtered to include only high-confidence microRNAs 
showing absence of other non-coding RNA species in the region; folding of the pre-miRNA into 
a hairpin; and homogenous reads in small-RNA sequencing data for both the 5’ and 3’ mature 
miRNA. We required conservation of the hairpin structure in orthologous members of the gene 
family for conserved microRNAs (as defined in mirBase) including mouse or other mammals and 
conservation of the seed in more than 50 per cent of the orthologous genes. The miRNAs used is 
from (4) and includes 229 miRNAs; 138 classified as broadly conserved; 52 classified as weakly 
conserved; and 39 as non-conserved. We determined the exact Microprocessor cleavage sites 
using the annotation of the 5p and 3p miRNA strands from miRBase and mapped them onto the 
sequence of the pre-miRNA. 
 
TNT-seq 
For one TNT-seq sample ~ 25 150mm plates were used for BrU labelling. RNA was metabolically 
labelled with BrU for 15 minutes and RNA was isolated as described above. RNA concentration 
was adjusted to 2μg/μl with nuclease free water. 18 μl of RNA was added to thin-walled 200µl 
PCR tube following addition of 2 μl of 10X fragmentation mixture (containing 800 µl of RNase-
free water, 100 µl of 1M Tris-HCl pH 7.4 and 100 µl 1M of ZnCl2). After vortex and quick 
spinning, the tubes were incubated in 94 °C for 3.5 minutes in a preheated thermal cycler block 
with the heated lid closed. Tubes were quickly removed from the thermocycler and placed on ice 
following addition of 2 µl of 0.5 M EDTA. After vortex and quick spin the RNA was collected 
in a tube to continue with for RNA precipitation using 1/10 volumes of 3 M sodium acetate (pH 
5.2), 3-4 volumes of 100% ethanol. RNA was allowed to precipitate at −80 °C overnight. The 
following day tubes were centrifuged at full speed for 30 minutes at 4 °C. RNA pellet was washed 
twice with 75% ethanol and resuspended in 400-500 μl of RNase-free water. Validation of post 
fragmentation size (~100 nt) distribution was analyzed using Agilent 2,100 Bioanalyzer with an 
Agilent RNA 6,000 Pico kit according to the manufacturer’s instructions. 400 μg-600 μg 
fragmented BrU labeled total RNA was used for each BrU-IP. BrU-RNA isolation was performed 
as described above. The BrU-IP recovery was approximately 0.09-0.16% of input. 4.5 μg of BrU 
fragmented RNA was used as input for the m6A immunoprecipitation. 35 μl of Dynabeads® 
Protein A (Invitrogen) per sample was transferred to a 1.5 ml microfuge Protein LoBind tube and 
washed 3 times with 1X m6A-IP (500 mM NaCl, 0.1% NP-40, 10 mM Tris-HCl, pH 7.5). After 
final wash the beads were resuspend in 800 μl 1X m6A-IP buffer supplemented with SUPERase• 
In™ RNase Inhibitor 1:1000.  1μg of affinity purified anti-m6A polyclonal antibody (Synaptic 
Systems) per 2.5 μg BrU-RNA was added to the beads and incubated for 60 minutes at room 
temperature with gentle rotation. As a negative control, we used Dynabeads® Protein A magnetic 
beads bound to an irrelevant IgG. Beads were washed 3 times with m6A-IP 1X buffer for 5 min 
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on the rotator.  5 μg of BrU Fragmented RNA was used as input. RNA was heated up for 4 minutes 
at 65°C. 5X m6A-IP buffer (50 mM Tris-HCl, 750 mM NaCl and 0.5% (vol/vol) Igepal CA-6300 
supplemented with SUPERase• In™ RNase Inhibitor) was added to have the RNA in 1X m6A-
IP buffer. RNA-antibody-beads mixture was incubated for 2h at 4°C with gentle rotation in a final 
volume of 0.8ml in Protein low binding tubes. Three washing steps followed using m6A-IP 1X 
buffer (1st and 2nd wash) and high salt m6A-IP buffer (500 mM NaCl, 0.1% Igepal CA-6,300, 10 
mM Tris-HCl, pH 7.5) (3rd wash). For all wash steps, with the exception of the elution step, the 
beads were washed for 5 min then placed on a magnet and the wash buffers were discarded. At 
the last wash the Protein low binding tubes were replaced with DNA LoBind tubes. For elution 
80 μl of Elution buffer (1X m6A-IP buffer + 6.7 mM m6A nucleotides) were added directly on 
the beads and the tubes were incubated for 1hour with continuous shaking (1100rpm) at 4 °C. The 
beads were spin down and the supernatant was transferred to a clean tube. After the second round 
of elution the eluted RNA was precipitated using ethanol precipitation as described above. RNA 
pellet was resuspended in 15 μl RNase-free water and using Qubit® RNA HS Assay Kit we 
measured the RNA concentration following manufacturer’s instructions. 
 
qTNTchase-seq, qPCR, RT-PCR. 
RNA was metabolically labelled with BrU for 15 minutes and chased for 30 minutes as described 
above. RNA was purified using TRIzol following manufacturer’s instructions. 200 ug total BrU 
labeled RNA was used as Input for the BrU-RNA isolation. After the elution step (200 μl of 0.1% 
BSA and 25mM bromouridine in PBS) we added 50ul of 5X m6A-IP buffer.  4 μg (1μg ab per 
500ng RNA) m6A ab were coupled to 40ul Dynabeads® Protein A as described above, 
resuspended in 550 μl m6A-IP 1X buffer and added to the RNA mixture. RNA-antibody-beads 
mixture was incubated for 60 minutes at room temperature with gentle rotation. The supernatant 
was kept and RNA was isolated with TRIzol. The beads were washed 3 times for 5 minutes at RT 
(twice with low salt m6A-IP 1X buffer and last wash high salt m6A-IP 1X buffer). We eluted the 
RNA captured by m6A ab by competition as described in TNT-Seq section. cDNA synthesis was 
performed using the same amount of RNA (10-20 ng) from all fractions (Input BrU-RNA 0 min, 
Input BrU-RNA 30 minutes chase, Supernatant m6A-neg 0h, Supernatant m6A-neg 30 min chase, 
IP m6A-positive 0 min, IP m6A-positive 30 min chase). RT-PCR was performed using Q5 Hot 
Start High-Fidelity DNA Polymerase New England Biolabs with initial denaturation 98 °C 30s, 
then 32 cycles of 98 °C 10 s, 58 °C 20 s and 72 °C 55 s and final extension 72 °C 2 minutes. PCR 
products were resolved on agarose gel. Spike-in controls were in vitro transcribed using T7 RNA 
Polymerase Invitrogen following manufactures instructions.  For the methylated transcripts N6-
methyl-ATP (tri-link) was used in a ratio 4:1 to ATP in the in vitro transcription reaction. GFP 
and Luciferase sequences were used as template for the RNA transcription. For each qTNTchase-
seq sample before m6A IP, in vitro–transcribed transcripts with and without m6A modification 
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were mixed into the samples as spike-in controls at the indicated percentage of m6A-modified to 
m6A-unmodified transcript (Molinie et al., 2016).  For all samples after BrU-IP but before m6A-
IP we added 2.5x107 copies from each spike included: 0% GFP, and 20% luciferase. For the 
sequencing; Post- qTNTchase seq 1 μl of 1:2000 dilution of the universal ERCC spike-in control 
A (Invitrogen) was added to each fraction. 
 
SiRNA transfection 
HEK293 cells were transfected with four different siRNAs targeting METTL3 transcript (see 
Supplemetary table 1) using HiPerFect Transfection Reagent from QIAGEN. In brief, reverse 
transfection was performed using 1 x 106 cells for a single 100mm plate. Cells were seeded in a 
final 4ml final volume of media without antibiotics. 12ul of transfection reagent together with 
siRNAs (25nM final concertation) were incubated at room temperature in 1ml Opti-MEMTM I 
Reduced Serum Media after mixing for 20 minutes.  The transfection complexes were added 
dropwise into the plate. 16 hours after transfection 5 ml of cell culture media were added to each 
plate. 24 hours after the transfection we performed a second round of transfection using the same 
amount of transfection reagent and siRNAs as the first round. 40 hours after the first transfection 
5 ml of cell culture media were added to each plate. We analyzed knock down efficiency with 
western blot (anti-METTL3 Polyclonal antibody, protein tech Catalog.number: 15073-1-AP) and 
continued with BrU-Chase Seq 72 hours after the first round of transfection. The experiment was 
performed in duplicates.  
 
Transcript m6A level and splicing index 
The m6A level per transcript from the qTNTchase-seq experiment were calculated as described 
in (Molinie et al., 2016). The ratio of the RNA abundance for each transcript between the eluate 
and the supernatant was represented by the ratio of the overlapping strand-specific RNA read 
counts normalized to the ratio of the reads of the ERCC RNAs. We used the log2-transformed 
read counts of ERCC RNAs to fit a linear regression model, computing the eluate ERCC reads as 
a function of the supernatant ERCC reads with a coefficient of 1(not shown). The log2 ratio 
between ERCC eluate counts and supernatant counts was indicated by the intercept of the 
regression formula. Only the ERCC RNAs with at least 100 read counts were used in this pipeline.  
M6A level = E/(E+S*2^intercept). Eluate read counts (E), supernatant read counts (S), and the 
intercept of ERCC regression (intercept). We assessed the splicing efficiency per transcript as the 
ratio of the overlapping strand-specific split reads (extracted by using bedtools coverage –s –F 
1.0) to all (split + non-split) reads covering the transcript. 
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Quantitative real-time PCR 
RNA was reverse transcribed using the Goscript reverse transcription Promega A500. cDNA was 
quantified on an 7900HT Fast real time PCR system (Applied Biosystems) using the Go Taq 
qPCR Master Mix  Promega (A6001). The PCR was carried out using a standard protocol with 
melting curve. Primers for unspliced RNA transcripts were design to span exon – intron 5’ splice 
junction and exon – exon boundaries for spliced RNA transcripts. Splicing efficiency (SE) was 
determined by the ration of   2^-CTspliced / (2^-CTspliced+2^-CTunspliced) for each timepoint. SED was 
determined by the ration of   SED = 1/ ((1- SE0 min) * (1- SE60 min)) 
 
RNA sequencing and data analysis  
For the BrU-Chase Seq, the library preparation was performed using the TrueSeq Stranded Total 
RNA Kit (Illumina). Sequencing was performed on an Illumina HiSeq 2500 instrument to obtain 
around 200M reads per sample. For the TNT-Seq, 100 ng of Input BrU-labeled fragmented RNA 
and 100 ng of TNT-IP eluate RNA were subjected to library preparation following the TruSeq 
Stranded mRNA Library Preparation Kit instructions with some modifications. The protocol 
started from the first strand synthesis step and 3X Clean-NA-Beads beads volume was used for 
the buffer exchange to include shorter RNA fragments. Mapping of strand-specific reads to 
GRC37 genome assembly (hg19) was done using STAR (Dobin et al., 2013) and only uniquely 
mapped reads were kept for further downstream analyses. To extract read coverage per nucleotide 
position across the genome the strand-specific bed files were sorted by chromosome and start 
coordinate and converted into wig files with bedtools genomecov using –scale to normalize for 
library size. To assess the genome-wide correlation of the m6A signal from replicates, the ratio 
of normalized read counts per nucleotide position of IP to Eluate, rendering the m6A signal, was 
converted to bigWig using wigToBigWig (UCSC) and then bigWigCorrelate (UCSC) was used. 
To extract the m6A signal per nucleotide position in given intervals, the depth at each nucleotide 
position of the examined intervals (e.g. within +/- 500 bp windows around anchor points) was 
extracted using bedtools coverage –d –s from the m6A Input and the respective m6A IP, and then 
the ratio m6A IP/Input multiplied by (total number of mapped reads in the Input/ total number of 
mapped reads in the IP) was calculated. Then the average m6A signal was extracted at each 
nucleotide position from all examined entries. 
 
m6A peak calling 
We called m6A peaks based on a previously published pipeline (Ke et al., 2015; Ke et al., 2017). 
We first divided the genome into 20 bp non-overlapping bins with bedtools windowMaker and 
extracted the strand-specific read coverage from m6A Input and IP for all bins using bedtools 
coverageBed –s. Fisher’s exact test p-value was extracted from the matrix (bin Input read counts, 
bin IP read counts, total number of mapped reads in the Input, total number of mapped reads in 
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the IP) and adjusted by the Benjamini and Hochberg method to determine the false discovery rate 
(FDR). Only windows with a p-adjusted < 0.05 in all three replicates and fold enrichment (score) 
minimum four in at least two out of the three replicates were kept as significant. Adjacent 
significant bins were merged using bedtools mergeBed into broader peaks (finally 95 % of the 
peaks were in the range 20-100 nt long). In the case of broad peaks, the peak summit is the 
midpoint of the 20 nt window with the maximum score, or the midpoint of the interval of merged 
adjacent bins sharing same maximum score within the same peak. In a few cases, a broad peak 
was assigned more than one summits if it contained non-adjacent windows sharing the same 
maximum score, finally yielding 58102 m6A peaks and 58311 peak summits. Custom scripts 
were written in awk programming language.  
 
De novo motif search 
De novo motif search was run using HOMER (Heinz et al., 2010) within +/-150 nt intervals 
around the peak summit of 5651 best scoring exonic m6A peaks (minimum fold enrichment 20) 
and the same number of top best intronic peaks. Control sequences were generated from the 
respective input sequences with the scrambleFasta.pl script. Then, de novo motif search was run 
with ‘findsMotifs.pl input_sequences.fa fasta –basic –rna –len 6,7,8 –fasta 
scrambled_sequences’. The results were inspected in terms of enrichment, significance and the 
presence of common consensus sequences, with the four motifs displayed in Figure S1B being 
the most represented. Those were used to scan the input sequences for the presence of match 
occurrences using the ‘dna-pattern’ search tool from the RSAT suite (Medina-Rivera et al., 2015) 
with parameters ‘search given strand only, prevent overlapping matches, origin-start, return 
flanking nucleotide positions 2’. Motif search was also performed in the same number of random 
genomic intervals as a control, generated with bedtools (–length 300 –number 5651). The matches 
were aligned and the logo was generated with WebLogo3 (Crooks et al., 2004) . 
 
Splicing kinetics and predictive models 
To assess splicing efficiency we extracted the splicing index value Ѳ ψ  as in (Mukherjee et al., 
2017) . Ѳ equals to the ratio of the split reads mapping to the 5’ and 3’ SJ of an intron divided to 
the sum of split plus non-split reads (schematic representation in Figure 7A). The Ѳ value 
(representing Splicing Efficiency, SE) was extracted from all pulse-chase time points, for 13,532 
introns with at least five reads coverage in both 5’ and 3’ SJ, and used in k-means clustering with 
k = 3 to call three groups of distinct splicing efficiency (fast, medium and slow) (Figure 7E). The 
Splicing Efficiency Dynamics metric was calculated as SED = 1/ ((1.001- Ѳ 0 min) * (1.001- Ѳ 
60 min)) (plotted in the log scale for the three groups in Figure 7D). To assess constitutive versus 
alternative splicing we extracted the ψ value as in (Mukherjee et al., 2017) . ψ is the ratio of 
constitutive split reads assigned to a given intron’s 5’ and 3’ SJ to all split reads (i.e. split reads 
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from the given intron 5’ SJ to any downstream 3’SJ and from the intron’s 3’ SJ to any upstream 
5’ SJ, as depicted in Figure 7A). Therefore, ψ is in the range 0 to 1 with 1 meaning 100 % 
constitutive splicing. We then used the ψ value extracted from the pulse-chase time point 60 min 
(closer to steady-state) to perform k-means clustering with k = 2 and define two clusters of 
introns, constitutive (n = 11836, minimum ψ 0.5294) and alternative (n = 1696, maximum ψ 
0.5278). In the case of introns classified as alternative spliced (ψ < 0.5278) upstream or 
downstream exon skipping takes place. The following features were used in logistic and linear 
regression models to predict splicing efficiency kinetics and alternative versus constitutive 
splicing: The 5’ and 3’ splice site underlying sequence scores extracted using MaxEntScan 
(http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html); distance of the 5’ SJ to the 
annotated transcript first start site (TSS) and of the 3’ SJ to the last end site (TES); expression 
calculated as coverage (reads per kb) from the m6A Input RNA-seq (15 min BrU pulse) for the 
whole transcript interval where the intron belongs to; intron length; intron overall m6A signal 
extracted as the strand-specific m6A IP read coverage divided to m6A Input read coverage, 
normalized by (total number of mapped m6A Input reads * total number of mapped m6A IP 
reads); m6A signal calculated the same way at the 5’ SJ 100 nt exonic boundary, 5’ SJ 100 nt 
intronic boundary, 3’ SJ 100 nt exonic boundary and 3’ SJ 100 nt intronic boundary.  
To predict fast versus slow or alternative versus constitutive splicing, logistic regression was 
performed with R function glm (family = binomial) (all parameters apart from the sequence scores 
were first log scale transformed and all were then standardized). To evaluate the fitting of the 
model and assess discrimination, the Receiver Operating Characteristic Curve (ROC) and the area 
under the curve (AUC) were calculated with the R package ROCR (Sing et al., 2005). Linear 
regression to predict splicing efficiency using the continuous value ψ (in the range 0 to 1) was 
performed with R function lm().  
 
CLIP data analysis 
We used CLIP data for SRF3 and SRSF10 from69(Xiao et al., 2016)(GEO GSE71096). To 
calculate the relative SRSF10/SRSF3 binding per nucleotide position, we used the ModeScore 
column from the GEO submitted PARalyzer output file, which is the score of the highest signal 
divided to the sum value (signal+backround) and ranges from 0.5 to 1. We first extracted the 
coverage for each SRSF per nucleotide position in the +/500 nt window around 5’ or 3’ SJ, or per 
bin for the length-binned introns (introns with length 1000-10000 nt, binned into 1000 non-
overlapping windows), by using bedtools coverage –s –d. Nucleotide positions with overlapping 
CLIP binding sites were assigned the cluster’s score (ModeScore column) whereas nucleotide 
positions with no CLIP data overlap were assigned a pseudo-score 0.1. We then computed the 
ratio SRFS10/SRSF3 per nucleotide position or per bin of all analyzed loci and the metagene 
27
analysis extracting the average ratio SRFS10/SRSF3 per nucleotide position or per bin was run 
separately for each of the subgroups fast/medium/slow or constitutive/alternative. 
_____________________________________________________________________________ 
Primer Sequences   Integrated Device Technology, Inc. (IDT)   
_____________________________________________________________________________ 
NAME Sequence 
CDKN1B unspliced Forward AATAAGGAAGCGACCTGCAA 
CDKN1B unspliced Reverse atacgccgaaaagcaagcta 
CDKN1B spliced Forward AATAAGGAAGCGACCTGCAA 
CDKN1B spliced Reverse GGGGAACCGTCTGAAACAT 
LMAN2 unspliced Forward GTGACTGCGGATATAACTGACG 
LMAN2 unspliced Reverse ctcgccctcactcttcactc 
LMAN2 spliced Forward GTGACTGCGGATATAACTGACG 
LMAN2 spliced Reverse ATAGTGCTGCCCTGGAAGTC 
NASP unspliced Forward CATGGAGTCCACAGCCACT 
NASP unspliced Reverse tgccttaagctttccacagtc 
NASP spliced Forward CATGGAGTCCACAGCCACT 
NASP spliced Reverse GCAGATGTAGAAGGAGCAGGA 
ARF4 unspliced Forward CCTCCCTCTTCTCCCGACT 
ARF4 unspliced Reverse attgtggagaccctgccttt 
ARF4 spliced Forward CCTCCCTCTTCTCCCGACT 
ARF4 spliced Reverse TTGTCTTGCCAGCAGCATC 
C8orf33 Forward TAAGAAGAAAACGCGGAACAGG 
C8orf33 Reverse GGTGGGTTTCTGCCTCTTGA 
MSN unspliced Forward TCAAGAAGCTGAAGAGGCCA 
MSN unspliced Reverse agttcccataatcccagccc 
MSN spliced Reverse CTGTCAGCTCTGCCATTTCC 
SPTBN1 unspliced Forward CTGGATGAGCGAGCAGGAG 
SPTBN1 unspliced Reverse aagtgtgcccagggtttgaa 
SPTBN1 spliced Revers GCATAGTCCTCCACAGCTTGT 
NOL7 unspliced Forward TCCTGAAGGAGAAGAGGAAGC 
NOL7 unspliced Forward aattctccctgagccgagtt 
NOL7 spliced Forward AACGCTCCTGAAGGAGAAGA 
NOL7 spliced Reverse TCCAAAATAGTGTCTGGAAGGA 
Pri-let7a1/d/f1 Forward GCATTTGTTTATGGCCTGGA 
Pri-let7a1/d/f1 Forward CACCCCCATCCAGTGTACTT 
Pri-let7a1 unprocessed F ACACCCACCACTGGGAGATA 
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Pri-let7a1 unprocessed R GCCTGGATGCAGACTTTTCT 
Pri-miR221/2 Forward AGCAAAGAGAACACCAATCCTGT 
Pri--miR221/2 Reverse GTTCCAAGCTTTCCTCCCATGAT 
Pri-mir221 unprocessed F ACTTGCAAGCTGAACATCCA 
Pri-mir221 unprocessed R TGCCTAACGAACACAGAAATCT 
 
” published in ref.2–4. 
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3. Results   
_____________________________________________________________________________ 
3.1. Set-up of nascent RNA pulse-chase sequencing3,4 
RNA-seq provides an average view of RNA in the cell or in the respective purified 
subcellular compartment, reflecting a mixture of RNA of different age compared to the time of 
Figure 4: Set-up of nascent RNA pulse-chase sequencing 
(A) Workflow for RNA pulse-labeling with BrU and chase to follow nascent RNA. (B) Calibration curve for 5ug 
BrdU antibody. (C) Bioanalyser Results from BrU-RNA labelled for 30 minutes and 15 minutes. (D-G) Bioanalyzer 
results for BrU-Chase Seq time points 0, 15,30, 60 minutes. The indicated RNA fragmentation time is according to 
TruSeq Stranded mRNA library prep kit protocol 
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transcription. To follow RNA from transcription through processing, nascent RNA can be 
obtained by labelling actively transcribed RNA with a pulse of a modified nucleotide analogue 
that allows for subsequent purification.  
For this study we chose BrU analog to label nascent RNA not only because it does not 
affect cell growth, but also because it is a simple and a cost-effective technic; ideally suited for 
in vivo studies30. We established BrU-Chase Seq (Figure 4A) from ref.81 with some 
modifications that improved the quality of the BrU labelled RNA. First, we reduced the BrU 
pulse time to 15 minutes instead of 30 minutes. The 15 minutes labelling time was the fittest 
and earliest time point from a series of calibrating timepoints that gave enough nascent RNA as 
output for further experiments. We compared the Bioanalyser results from isolated BrU labelled 
RNA of 30 minutes versus 15 minutes pulse and observed that the length distribution of the two 
timepoints differ. More specifically, the majority of the nascent transcripts isolated from the 15 
minutes pulse are longer than 4000 nt whereas the majority of transcripts from 30 minutes pulse 
are approximately 2000 nt (Figure 4B). This implicates that within 30 minutes pulse, the 
isolated RNA is enriched in many transcripts that undergo processing. Second, we calibrated the 
amount of Total labelled RNA (Input) that is needed to saturate 5 μg of BrdU antibody and 
found that ~50 μg Total labelled RNA should be used per 5 μg BrdU antibody (Figure 4C). 
Third, we eluted the BrU labelled RNA bound to the antibody via BrU competition rather than 
heating for 10 minutes in 80 °C. In this way, we isolate only the RNA molecules that are bound 
to the BrdU-coupled beads and at the same time, we avoid any degradation of the RNA caused 
by high temperatures.  Fourth, the eluted BrU labelled RNA from all time points was subjected 
to Bioanalyser analysis for quality check. In addition, according to the Bioanalyzer results, 
RNA was fragmented during different incubation times at 94 °C (Figure 4D-G) prior to the 
library preparation. Finally, we subjected BrU labelled nascent RNA from all chased time points 
obtained from HEK293 cells to next-generation sequencing using an Illumina Hi-Seq 2500 to 
obtain around 200 M reads per sample. In our data we did not observe rRNA enrichment in the 
eluted BrU-labelled RNA (Figure 4D-G). Given that the rRNA synthesis and ribosome 
biogenesis are regulated to meet cells growth rate and proliferation and that the average 
doubling time of HEK293 is 24h, it is unlikely that within 15 minutes BrU pulse we could 
capture rRNA transcription82. (See Appendix: Metabolic Pulse-Chase RNA Labeling for pri-
miRNA Processing Dynamics Chapter published in3 for further details regarding the protocol). 
 
3.2. In vivo profiles of pri-miRNA processing dynamics from whole cells3 
 To further extend our previous findings18 on steady-state pri-miRNA processing efficiency 
we used nascent RNA obtained after a short (15 min) BrU pulse and subsequent chase for 0, 15, 
30 and 60 minutes (Samples 15, 30, 45 and 75 min after BrU, respectively) to follow the 
processing kinetics. We have previously reported a specific profile for steady-state chromatin-
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associated RNA around the site of pre-miRNA processing within the pri-miRNA transcript18 
(Figure 5A). Following the nascent RNA during the chase we could record the time-course of 
processing of pri-miRNAs in HEK293 cells. Interestingly, for the 38 pri-miRNAs (see appendix) 
where we observed a pronounced profile, we noticed different processing kinetics across pri-
miRNA transcripts, and within polycistronic pri-miRNAs. The profiles for miR-221, let-7a-1 are 
depicted in Figure 5B to represent the intermediate and fast processing kinetics.  The profile of 
miR-21 was chosen as a representative for not a pronounced processing profile. The processing 
efficiencies were analysed also using quantitative PCR (qPCR) of individual pri-miRNAs, as 
shown for miR-221, let-7a-1 and miR-21 in Figure 5C. As described in ref.18, we used primers 
spanning the processing site  and primers amplifying the total of pri-miRNA transcript (processed 
and unprocessed) to determine the relative amounts of unprocessed pri-miRNAs. 
Figure 5: In vivo profiles of pri-miRNAs processing dynamics from whole cells 
(A) Concept of processing signature in pri-miRNAs. Processing extent is calculated as the read-density in 
the pre-miRNA region compared to the flanking regions. Processing efficiency is calculated as (1 – 
processing extent). (B) Processing signatures in RNA-sequencing data from nascent RNA in pulse-chase 
experiment for pri-miR-221, pri-let-7a-1 and pri-miR-21. (C) Quantification by PCR of 
unprocessed/primary pri-miRNA for examples shown in c from two independent experiments. 
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3.3. Differential processing within polycistronic pri-miRNAs3 
 Many miRNAs are expressed from polycistronic pri-miRNAs and these miRNAs often 
belong to the same families and thus predicted to target the same mRNAs for translation 
regulation and target RNA degradation 83,84. Let-7a/f and miR-221/222  are prominent 
polycistronic pri-miRNAs with crucial roles in the development of cancer and cell cycle85. We 
found differential processing kinetics within both these polycistronic pri-miRNAs. The miR-
221/222 pri-miRNA is a 25kb long transcript (Figure 6A) encoding miR-221 and miR-222. 
While the two miRNAs are adjacent to each other, they exhibit very different processing 
kinetics (Figure 6B-C), demonstrating that processing kinetics, for the miR-221/222  cluster, 
are not defined by the primary transcript or its association to chromatin, as has recently been 
suggested86. The processing efficiency of miR-221 and miR-222 over time was quantified by 
qPCR shown in (Figure 6C). 
 
 
 
Figure 6: Differential processing within polycistronic pri-miRNAs 
(A) Overview of the genomic region and full pri-miRNA transcript. (B) Enlarged read-densities around 
pre-miRNAs for miR-221 and miR-222. (C-D) Quantification by PCR of unprocessed/primary pri-
miRNA for (C) miR-221 and miR-222. 
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3.4. In vivo profiles of pre-mRNA processing dynamics from whole cells2 
 To study the splicing kinetics of nascent RNA, we calculated the splicing index value 
Ѳ36(Figure 7A) and we determined the splicing efficiency across all time points for introns that 
had at least 5 reads coverage on both 5’ and 3’ SJ for all RNA sequencing libraries (four time 
points of BrU Chase-seq and the three Input samples for TNT-seq). Accordingly, we extracted 
the Ѳ value from 13,532 introns, ranging from 0 (unspliced) to 1 (fully spliced). We calculated 
the cumulative distribution of the splicing index for all four time points and steady-state 
chromatin-associated RNA18 and as expected, the BrU-Chase Seq 0 min, captured more unspliced 
pre-mRNAs than CA-RNA and rest of the BrU-Chase Seq time points (Figure 7B). 
Figure 7: In vivo profiles of pre-mRNA processing dynamics from whole cells. 
(A) Definition of Ѳ and ψ value. (B) Cumulative distribution of the SE index from chromatin-associated 
RNA-seq (Conrad et al., 2014), BrU-Chase Seq 0 min, 15 min, 30 min and 60 min. (C) Box plot 
representing the density of the SE index (θ value) distribution for introns grouped on the basis of 
differential splicing kinetics. (D) Boxplot showing distribution of the Splicing Efficiency Dynamics 
(SED) for the Fast, Medium and Slow processed intron groups. SED=1/((1.001-SE 0 min)*(1.001-SE 60 
min)) (E) Heatmap showing the k-means clustering results (with k = 3) of the splicing SE index (θ value) 
of the 13,532 filtered introns measured for the BrU-Chase time points. Introns are clustered into fast-, 
medium- and slow-processed. (F) UCSC genome-browser views of representative cases of introns from 
each of the three clustering groups. 
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Using k-means clustering with k = 3 we obtained three clusters of distinct splicing efficiency 
dynamics (SED) representing 4,882 fast, 5,702 medium, and 2,948 slowly processed introns 
(Figure 7C-E). The value of SED is calculated by SED=1/ ((1.001-SE 0 min) * (1.001-SE 60 
min)) and represents the splicing dynamics for each intron including the initial splicing efficiency 
(SE 0 min). Snapshots from the UCSC genome browser for three representative cases are shown 
in Figure 7F. 
 
3.5. Transient N-6-methyladensosine Transcriptome sequencing2 
 We developed TNT-seq, a technique to detect m6A on nascent RNA, enabling us to study 
the deposition of m6A on short-lived RNA processing intermediates. Concisely, we applied 
MeRIP-Seq43,45 on metabolically labeled transcripts that are produced within a 15 minutes 
window of active transcription (Figure 8A). Directly after a 15 minutes BrU-pulse, cells were 
collected and the isolated RNA was heat-fragmented to ~100 nt length. After calibration 
experiments, we chose 94°C for 3 minutes to succeed the desired fragment length (Figure 1B). 
The length of the RNA fragments was also verified with Agilent 2100 Bioanalyser shown in 
(Figure 8C). BrU-labeled RNA was subsequently eluted via BrU competition, to reduce 
background from contaminating unlabeled RNA, and the eluate was then subjected to 
immunoprecipitation with an m6A-specific antibody to enrich for methylated RNA fragments. 
The BrU-labeled nascent RNA (BrU-RNA Input) and the m6A enriched RNA fragments (BrU-
m6A-RNA IP eluate) were then subjected to deep sequencing to identify positions of m6A on 
nascent RNA (Figure 8A). We detected localized enrichment of m6A deposition at start and stop 
codons as well as at 5’ and 3’ SJs as a reproducible profile from independent replicates (Figure 
8D), suggesting a robust experimental pipeline (genome-wide m6A signal correlation = 0.58).  
 
3.6. TNT-seq reveals m6A deposition on newly transcribed RNA2 
m6A peaks were called using a published pipeline44. We show in Figure 9A that the majority 
of early m6A peaks (57 %) reside within intronic sequences, 22 % in coding sequences (CDS), 
5 % in 5’ UTRs and 9 % in 3’ UTRs. To compare m6A peak distribution in newly transcribed 
RNA with steady-state mRNA we reexamined MeRIP-Seq data from ref.3 and called m6A peaks 
using the same pipeline. The majority of steady-state mRNA m6A peaks reside in the CDS 
(52 %), 3’ UTR (28 %) and 5’ UTR (12 %), while only a minor fraction (4 %) is intronic (Figure 
9B). Nearly half of the CDS-associated nascent m6A peaks reside within 100 nt upstream of the 
5’ SJ and about one fifth are within 100 nt downstream of the 3’SJ (Figure 9A). For steady-state 
mRNA only 17 and 11 % of the CDS peaks are within the respective intervals, which could 
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suggest a transient functional role of early m6A deposition (Figure 9B). We normalized the 
number of m6A peaks to the length of the analyzed intervals and the respective input read 
coverage and find that the early m6A deposition is enriched within 100 nt of the 5’ SJ exonic 
boundary (Figure 9C-D). To validate the authenticity of m6A sites on nascent RNA we evaluated 
the presence of the DRACH m6A consensus motif by performing a de novo motif search with 
HOMER in the regions +/-150 nt around the peak summit of best scoring peaks (score > 20, n= 
5651) or in randomly generated 300 nt genomic intervals (See Methods under ‘De novo Motif 
Search’). This analysis showed a positional enrichment of a DGACH motif, around the m6A peak 
summits in particular for exonic peaks (Figure 9E). Furthermore, by de novo motif search we 
identified three additional motifs, sharing a SAG core, with a strong positional enrichment around 
the peak summit, especially for intronic peaks (Figure 9E). Then, we analyzed the positional 
distribution of m6A peak summits around 5’ SJs, 3’ SJs, and start- and stop-codon anchor points 
for both newly transcribed and steady-state mRNA (Figure 9F).  Early m6A peaks at and in close 
Figure 8: Transient N-6-methyladensosine Transcriptome sequencing 
 (A) Schematic representation of the TNT-seq protocol. (B) Agarose gel analysis of RNA fragments with 
different heat fragmentation conditions. (C) Bioanalyser Results of RNA fragmented for 3 minutes in 94 °C 
and before fragmentation-total RNA.  (D) Average m6A signal per nucleotide position around start and 
stop codons, 5´ and 3´ SJs for the two TNT-Seq replicates 
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proximity to splice junctions are relatively more compared to steady-state mRNA m6A peaks 
(Figure 9G-H), whereas around start- and stop-codons the picture is inversed (Figure 9F, I). This 
result led us to examine whether early m6A deposition in close proximity to SJs has a role in 
splicing of RNA. 
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 3.7. m6A signatures separate distinct intron classes2 
To study how early m6A deposition varies with different processing efficiencies, we plotted 
the average m6A signal per nucleotide position around 5’ and 3’ SJ (Figure 10A, B, D, E) and 
within length-binned introns for the three groups (Figure 10C). To avoid the overlap of +/- 500nt 
from 5’ and 3’ SJ we analysed 6742 with length 1000-10000 nt and their adjacent 5´ and 3 ´SJ 
but also the average m6A signal of 5’ and 3’ SJ for all 13532 introns. Notably, we found that fast 
processed introns show greater m6A deposition at SJs with an overall positive relationship 
between m6A deposited at 5’ and 3’ SJ exonic boundaries and processing efficiency (Figure 10A, 
B, D, E). We reached the same conclusion also when we plotted the average frequency of m6A 
peak summits per nucleotide position (instead of the average m6A signal) for the three subgroups 
(Figure 10G-I). Contrary, slowly processed introns are associated with increased m6A deposition 
within the intron (Figure 10B, H). To address whether the position of an intron affects m6A 
signal and splicing efficiency we plotted the average m6A signal per nucleotide position around 
the 5’ and 3’ SJs of only the first and last introns (of transcripts with at least four exons). This 
analysis show that the observed effect is independent of the position of the intron (Figure 10K-
M). 
3.8. m6A deposition at nascent RNA predicts splicing efficiency dynamics2  
 To further investigate the role of early m6A sites in shaping the splicing efficiency dynamics 
we used several features in a logistic regression model fit to predict fast versus slowly processed 
introns (Figure 11A, B). We show that inclusion of the m6A signal at SJs as an additional 
parameter improves the predictive power of the model (Figure 11A), with the m6A contribution 
in predicting fast processing being comparable to other previously shown features36, such as the 
5’ and 3’ SJ sequence scores and distance to TSS/TES (Figure 11B). In contrast, the overall 
intronic internal m6A signal and intron length are significantly associated with slow processing 
(Figure 11B).  
 
Figure 9: TNT-seq reveals m6A deposition on newly transcribed RNA 
 m6A peak distribution in (A) newly transcribed RNA and (B) mRNA from51 . (C) Distribution of the 
normalized number of m6A peaks to the length of the analyzed intervals and (D) the respective input read 
coverage for TNT-seq and mRNA m6A-seq data51. (E) Number of motif occurrences (sum) at nucleotide 
positions around the m6A peak summit of the top scoring 5,651 exonic peaks, intronic peaks or random 
intervals. The line represents loess curve fitting (local polynomial regression) with the 95% confidence interval 
shaded grey. (F) Distribution (frequency) of the distance of m6A peak summits to the closest given anchor 
point, (E) Start codon; (G) 5΄SJ, (H) 3΄SJ and (I) Stop codon for nascent RNA (TNT-Seq) and mRNA (m6A-
Seq51). 
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 Figure 10: m6A signatures separate distinct intron classes. 
Average m6A signal per nucleotide position in a +/- 500 nt window around (A, B) 5΄SJ and (D, E) 3΄SJ of the 
13532 filtered introns and for the 6742 introns with length 1000-10000 nt, for fast, medium and slow processed 
introns. (C) Average m6A signal per nucleotide position internally per bin for 6742 introns (with length 1000-
10000 nt), for fast, medium and slow processed introns. (F-H) Average frequency of m6A peak summits per 
nucleotide position in the window +/- 500 nt around (F) 5’ SJ, (H) 3’ SJ of all 13,532 filtered introns, and (G) 
per bin of 6722 introns 1000-10000 nt long, extracted separately for fast, medium, slow subgroups. The lines 
represent loess curve fitting (local polynomial regression) with the 95% confidence interval grey shaded. (K-M) 
Average m6A signal per nucleotide position around the 5’ and 3’ SJs of only the first and last introns. n = 
number of introns 
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 3.9. Internal intronic m6A deposition associates with alternative splicing2. 
 Slow pre-mRNA processing has been linked with the occurrence of alternative splicing, i.e. 
exon-skipping36. We examined alternative versus constitutive splicing by extracting the intron-
centric ψ value as in ref.36 (Figure 12A). Our analysis further supports that alternative splicing 
events are significantly enriched in slowly processed introns (odds ratio 3.84, Fisher’s exact test 
p-value < 2.2e-16) (Figure 12A). We next asked whether intronic m6A deposition could affect 
alternative splicing. We show that intronic m6A peaks correlate with upstream or downstream 
exon-skipping about two times more often than expected by random chance (odds ratio 1.7, 
Fisher’s exact test p-value < 2.2e-16), indicating that internal intronic m6A deposition is 
significantly enriched in alternative splicing events. In agreement, we found that the average m6A 
signal is greater along alternative versus constitutively spliced introns (Figure 12C) and that the 
average m6A signal is greater at constitutive versus alternatively spliced SJ exonic boundaries 
(Figure 12B, 12D). In the prediction of alternative versus constitutive splicing shown in Figure 
12E, the overall intronic m6A, along with the physical characteristic of intron length, are 
significant contributors in determining alternative splicing. On the other hand, m6A at SJ exonic 
boundaries and strong splice site consensus sequences (SJ score) ensure constitutive splicing 
(Figure 12E). The inclusion of m6A signal once more improves the predictive power of the model 
Figure 11: m6A deposition at nascent RNA predicts splicing efficiency dynamics  
(A) Average receiver operating characteristics (ROC) curve for discrimination of fast versus slow introns 
including all characteristics and excluding m6A. The respective Area Under the Curve (AUC number) is 
indicated. (B) Contribution of each feature to the model fit of fast versus slow processing calculated as the 
coefficients from the binary logistic regression with the associated estimated significance (-log10 p-
value). The features with p-value <0.001 are colored red 
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fit of constitutive versus alternative splicing (Figure 12F), highlighting the impact of m6A 
deposition on nascent RNA in shaping splicing efficiency. 
 
 
 
 
Figure 12: Intronic m6A deposition associates with alternative splicing  
(A) Violin plots showing density of the distribution (with embedded box-and-whiskers plots) of θ value 
for introns classified as either constitutive or alternative spliced extracted from all pulse-chase time 
points. (B-D) Average m6A signal per nucleotide position in a +/- 500 nt window around (B) the 5’ SJ 
and (D) 3’ SJ, and per bin (C) of 6,742 introns with length 1,000-10,000 nt. The average m6A signal is 
extracted separately for the two subgroups, constitutive and alternative. The lines represent loess curve 
fitting (local polynomial regression) with the 95% confidence interval shaded grey. (E) The contribution 
of each feature to alternative versus constitutive splicing, calculated as the coefficients of the binary 
logistic regression fit with associated estimated significance (-log10 p-value). Features with p<0.001 are 
colored red. (F) Average ROC for the logistic regression prediction of the alternative versus constitutive 
splicing using all features, with and without m6A data. The respective AUC number is indicated. 
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3.10. qTNTchase-seq identifies m6A-marked fast-track RNAs2 
  We examined the direct impact of m6A modifications at the individual transcript level by 
developing and applying qTNTchase-seq (quantitative TNT pulse-chase sequencing). This 
method enabled us to clearly separate directly m6A-mediated from sequence specific effects on 
RNA processing. Here, labeled RNA was isolated at 0 and 30 min chase after a short BrU pulse 
and then, without prior fragmentation to maintain transcript level information and the m6A 
methylated transcripts were immunoprecipitated with an m6A-specific antibody (Figure 13A). 
Importantly, we kept the supernatant representing the m6A negative transcripts, and both the 
supernatant (m6A negative transcripts) and the eluate (m6A positive transcripts) from each time-
point were sequenced to obtain quantitative information. To validate that qTNTchase-seq can 
quantify m6A levels or stoichiometry, we mixed non-mammalian m6A-modified RNAs and 
unmodified RNAs generated in vitro, at ratios ranging from 0% for GFP and 20% for Luciferase 
(modified to unmodified). qPCR measurements prior to sequencing showed a quantitative 
Figure 13: qTNTchase-seq set up 
(A) Schematic description of the qTNTchase-seq method. (B) qPCR measurments of spike in GFP 
enrichment in the Inputs 0 min, 30min, Eluates (m6A pos 0 min, 30min,) and Supernatant (m6A neg 0 
min, 30min). (C) qTNTchase-seq quantifies m6A levels. Scatterplot comparing expected versus observed 
spike in % ratio of 0% GFP and 20% Luciferase. The spike ins were generated in vitro, with each 
transcript harboring m6A modifications mixed with unmodified counterparts at indicated ratios as spike-
ins before anti-m6A RIP. The error bars represent standard error (n=2). 
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agreement with the known stoichiometry (Figure 13B-C). We performed two biological 
replicates of qTNTchase-seq and calculated the m6A levels per transcript according to ref.80. On 
a transcriptome-wide scale we observe a strong concordance of m6A levels between the two 
biological replicates, irrespective if only the top 25% expressed transcripts or all transcripts with 
non-zero coverage are included in the analysis (for 0 minutes Pearson r = 0.89 p value < 2.2e-16 
and for 30 min Pearson r = 0.91 p value < 2.2e-16) (Figure 13D-E). When comparing m6A levels 
between 0 min and 30 min chase we did not observe any significant differences indicating that 
overall m6A modification levels on transcripts remain the same for at least ~45 minutes after 
transcription (Figure 14A). Then, we analysed splicing efficiency on the transcript level by 
extracting the transcript splicing index and compared this for methylated versus non-methylated 
transcripts at 0 min and 30 min separately. Within the pulse (0 min), corresponding to a 15-minute 
window of transcription, methylated transcripts show significantly higher splicing efficiency than 
non-methylated transcripts (Figure 14B), further supporting the role of the early m6A deposition 
in enhancing processing efficiency. In addition, by measuring the splicing efficiency dynamics 
(SED) at the transcript level from 0 to 30 minutes chase, we show that methylated transcripts 
Figure 14: qTNTchase-seq identifies m6A-marked fast-track RNAs 
(A) Density plot of the log2 ratio of the m6A levels per transcript measured at 30 minutes divided to 0 
minutes (all transcripts with non-zero coverage. (B) Box plot representing the overall SE of methylated 
(m6A positive) versus non-methylated (m6A negative) transcripts at time points 0 min and 30 min. (C) 
Violin plots showing distribution of the transcript SED in m6A positive and m6A negative fractions (two-
tailed Student’s t-test p-value < 2.2e-16). (D) Cumulative distribution of transcript SED differences 
between the methylated and unmethylated state (∆SED = SED m6A-positive – SED m6A-negative). (E) 
Box plot displaying SED per intron in m6A positive and m6A negative transcripts (two tailed paired t-test 
p-value < 2.2e-16). 
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show on average significantly greater processing than unmethylated transcripts (two tailed paired 
t-test p-value < 2.2e-16) (Figure 14C). Notably, processing is significantly enhanced for the same 
individual transcripts in the methylated compared to the unmethylated state; ~76% of the 
transcripts show gain of SED in the methylated versus unmethylated state revealing a direct and 
sequence independent role of m6A on processing kinetics (Figure 14D). Furthermore, we 
examined locally the splicing efficiency for the dataset of the 13,532 filtered introns. We found, 
that ~14% have significantly higher splicing efficiency in the m6A positive than in the m6A 
negative transcripts and show a 1.26 fold enrichment over random chance to possess an m6A peak 
in the 5’ SJ 250 nt exonic boundary (odds ratio 1.265, Fisher’s exact test p-value 0.0006745). In 
addition, individual intron loci show on average significantly higher SED in methylated versus 
non-methylated transcripts (two tailed paired t- test p-value < 2.2e-16) (Figure 14E). We then, 
analyzed the splicing kinetics of four candidate splice junctions that have at least one m6A peak 
(+/-250nt) by qPCR on qTNTchase-seq RNA. We calculated splicing efficiency as the ratio of 
the spliced signal over total (spliced + unspliced) signal. Notably, at time point 0 min, methylated 
transcripts show higher splicing efficiency compared to their unmethylated counterparts that share 
the same nucleotide sequence (Figure 15A-B). This result was recapitulated with RT-PCR 
analysis where the fragments corresponding to spliced and unspliced transcripts were analyzed 
on an agarose gel, showing the positive effect of m6A on RNA splicing (Figure 15C) 
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Figure 15: m6A-mediated effects on RNA processing is independent from the underlining sequence. 
(A) UCSC genome browser tracks of qTNTchase-seq data representing the transcript regions used for the RT-
qPCR analysis. Normalized read coverage (reads per million of total number of mapped reads) tracks for Input 
(blue), Supernatant m6A negative (grey), Eluate m6A positive (pink). The upper overlay track represents the 
TNT-seq with purple for Input and green for IP; black rectangles above represent the called m6A peaks. Below 
tracks for each sample are agarose gels depicting semi-quantitative PCR of Input, m6A positive and m6A 
negative samples for 0 min and 30 min. (B) qPCR analysis of the local intronic SE of methylated versus non-
methylated transcripts for 0 minutes and 30 min 
45
3.11. Splicing factors coincide with m6A deposition2 
We sought to investigate the functionality of early m6A positive role in regulating RNA 
processing. For this we analyzed available CLIP-data for SRSF factors with a known role in 
splicing. We found that both SRSF3 and SRSF10 show a high probability to have a m6A peak 
summit in close proximity (< 250 nt) (Figure 16A-B), with SRSF10 showing relatively greater 
affinity (Figure 16C). Furthermore, the SAG core that we identified by de novo motif search in 
early m6A peaks (Figure 9) is similar to the SRSF binding site motifs87. In addition, both SRSF3 
and SFRF10 have been shown to bind near m6A. More specifically, while SRSF3 binding can be 
synergistically augmented through interaction with YTHDC1, SRSF10 can independently bind to 
m6A modified regions69. In agreement, we found that the ratio of SRSF10/SRSF3 binding is 
greater at the SJ exonic boundaries for fast processed introns, and internally along within slowly 
processed introns (Figure 16D-F), in agreement with the respective relative enrichment of early 
m6A deposition (Figure 10). Furthermore, the average ratio of SRSF10/SRSF3 binding clearly 
separates alternative and constitutive spliced introns (Figure 16 G-I), most prominently along 
length-binned introns (Figure 16H). This result is in agreement with a previous study suggesting 
that alternative splicing activity can be antagonistically regulated by SRSF10 versus SRSF3 
binding10. The above data support that early m6A deposition could play an early role in shaping 
the final outcome of alternative splicing activity via resolving the relative recruitment of various 
splicing factors with varying m6A affinities. 
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 Figure 16: Splicing factors coincide with m6A deposition 
(A-C) Distribution of the interdistances of factor binding sites to closest m6A peak summit for (A) SRSF3 
(B) SRSF10 and (C) overlap. As a control, distance from the midpoint of the respectively same number of 
randomly generated genomic intervals is also plotted. (D-F) Distribution of the average ratio 
SRSF10/SRSF3 binding, extracted separately for the three subgroups fast/medium/slow per nucleotide 
position in the window +/-500 nt around the 5’SJ (D) and 3’SJ (F), or per bin (E) for 6,742 length-binned 
introns (with a length 1,000-10,000 nt). (G-I) Same analysis as in (D-F) but comparing the average 
SRSF10/SRSF3 ratio for the two subgroups constitutive versus alternative. 
47
3.12. m6A effects are METTL3 dependent2 
To provide a direct link between RNA splicing kinetics and early m6A deposition at SJs we 
examined the splicing kinetics after METTL3 knock-down (60 min chase) (Figure 17A). We 
divided the intron dataset into three equal-size quantiles based on the m6A signal at 5’ and 3’SJ 
(5’ and 3’SJ 100 nt exonic intervals) and calculate the SED respectively. We plotted the log2 ratio 
of SED for METTL3 KD to Control for introns with low, medium and high m6A signal (Figure 
17B). For introns with high m6A signal on both 5’ and 3’SJ we notice a decreased SED upon 
METTL3 KD, for about half of the entries (log2 SED ratio METTL3 KD/Control <0) (Figure 
17B). For introns with medium and low m6A signal (log2 SED ratio METTL3 KD/Control > 0) 
we observe an increased SED (Figure 17B). The difference in the SED ratio (log2 METTL3 
KD/Control) of high m6A signal compared to low or medium is significant (t-test p-value < 2.2e-
16). Then, we focused on Fast processed introns and plotted the m6A signal (sum of 5’SJ and 
3’SJ 100 nt exonic area) for those that show reduced SED upon METTL3 KD versus the rest 
(Figure 17C). We found that the METTL3-affected introns have significantly higher m6A at the 
5’ and 3’SJ exonic boundaries. This confirms that the 5’ and 3’ SJ exonic methylation promotes 
Figure 17: Nascent m6A effects are METTL3-dependent 
(A) Western blot for METTL3 KD. (B) Log2 ratio of SED in METTL3 KD to Control for introns with low, 
medium and high m6A signal at both 5’ and 3’SJ (100 nt exonic area). (C) m6A signal at both 5’SJ and 
3’SJ (100 nt exonic area) for the Fast-processed introns that show reduced SED in the METTL3 KD 
condition versus the rest (two-tailed Student’s t-test p-value < 2.2e-16). (D) m6A signal at both 5’SJ and 
3’SJ (100 nt exonic area) for the Slow processed introns that show reduced SED in METTL3 KD condition 
versus the rest (two-tailed Student’s t-test p-value < 2.2e-16). (E-H) qPCR analysis of SED for (E-F) Fast 
(G) Medium and (H) Slow processed introns (n = 2 biological replicates, *p<0.05 and **p<0.01, two-tailed 
Student’s t-test) 
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fast splicing kinetics, as also shown by the logistic regression model fit (Figure 12). We observed 
the same but less pronounced tendency for the Slow processed introns (Figure 17D). Figures 
17E-H show qPCR analysis of SED for four candidates that are in agreement with the 
transcriptome-wide data. 
 
4. Discussion of the Thesis. 
____________________________________________________________ 
RNA is found everywhere in the cell; in different shapes, sizes, ages and most importantly 
RNA participates in a vast array of cellular events. At any given time, RNA transcripts can be 
found in different processing stages. As a consequence, studying the entire population of 
cellular RNA is extraordinarily complex. A way to tackle this complexity is to label, enrich and 
follow a population of RNA through time. Another way is to isolate a specific cellular 
compartment where most likely the nascent RNA will be found. In our study, we used a 
metabolic labelling pulse-chase approach to enrich for the nascent RNA transcribed within 15 
minutes of transcription. We show that the transcripts captured from this method are more 
nascent than cellular fractionation protocols23 (Figure 7b). BrU-Chase Seq is a method used by 
Paulsen et al.,30 to study the inflammation response in human cells. The inflammatory response 
in human fibroblast involves rapid and dramatic gene expression changes that could be captured 
by the BrU-Chase Seq method. Our questions revolved around RNA processing of pri-miRNA 
and pre-mRNA and to answer them we established an improved version of BrU-Chase Seq4. 
BrU-Chase Seq revealed the complexity of pri-miRNA processing with distinct processing 
dynamics. Given that the miRNA expression is directly related to the pri-miRNA processing 
rather than pri-miRNA expression18, it is important to understand which is the molecular 
mechanism that drives the different processing kinetics. Several protein co-factors may facilitate 
or inhibit the miRNA biogenesis either through the recruitment of Microprocessor to the pri-
miRNA transcripts86 or by inhibiting Microprocessors binding. Our method4 allowed us to 
detect the differential processing within polycistronic pri-miRNAs. More specifically, miR-221 
and miR-222 are derived from the same pri-miRNA gene however, miR-222 has faster 
processing than miR-221. The miR-221/222 cluster is characterised as oncogene and shares 
many targets such as p27 tumor suppressor85. On the other hand, miR-221 and miR-222 have 
also non-overlapping targets suggesting that processing kinetics could define the biological 
regulation that could modulate the levels of miRNAs against a specific target through-out the 
cell cycle. It would be interesting to study at a single RNA molecule level whether these 
miRNAs are processed from the same pri-miRNA transcript copy. Single RNA molecule 
analysis coupled to FRET technology (smFRET)88,89 should help answering this question. 
The second part of the thesis provides the first high-resolution view of the transient, 
nascent N-6-methyladenosine transcriptome2. We identify an enrichment of m6A deposition 
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near the 5’ SJs of nascent RNA transcripts and we find that early m6A deposition at SJs and 
within introns is associated with distinct RNA processing kinetics. A recent study from Ke et al. 
that was conducted in HeLa cells, reported that m6A is deposited mostly on chromatin-
associated pre-mRNAs (CA-RNAs) while observing an enrichment of m6A peaks in exonic 
regions44. In agreement with our results they show an enrichment of m6A signal near exon-
intron junction implicating that the m6A deposition occurs before splicing. However, they 
report higher m6A peak density in the last exons relative to the rest in all three cell fractions; 
CA-RNAs, nucleoplasmic RNA and cytoplasmic RNA fraction44. These results show that the 
m6A is deposited in most pre-mRNAs while being attached to chromatin, before the splicing is 
completed and that the m6A distribution remains the same during the mRNAs release from 
chromatin (nucleoplasmic RNAs) and after their nuclear export (cytoplasmic RNAs). The 
establishment of m6A-CLIP90 allowed more precise identification of m6A signal already within 
~50nt away from the SJs that rises almost double at ~100nt. TNT-seq provides a direct 
assessment of m6A on nascent RNA and shows that the majority of m6A peaks is found within 
intronic sequences consistent with METTL3-METTL14 PAR-CLIP data showing 29 %-34 % 
intronic binding sites52. However, after normalizing the number of m6A peaks to the length of 
the analysed intervals and the respective input read coverage, we found in agreement with Ke et 
al., that the early m6A deposition is enriched within 100 nt of the 5’ SJ exonic boundary. On the 
other hand, the earliest time point BrU-Chase Seq time point 0 min (15 minutes BrU labeling 
without chase) captured more nascent RNA transcripts than CA-RNA18. The protocol for cell 
fractionation includes multiple biochemical steps to purify chromatin together with the 
associated RNA. The protocol lasts more than 15 minutes and is carried out in 4° that does not 
exclude the possibility that the transcription and processing is on during the phase separation23. 
Thus, the intronic sites that TNT-seq detected could be potentially removed at a later stage or 
co-transcriptionally while transcripts are still associated with chromatin. One hypothesis could 
be that RNA transcripts associated with chromatin are more prone to be bound by demethylases 
such as FTO. FTO loss of function experiments coupled with CA-RNA m6A-CLIPs are needed 
to exclude the above hypothesis. A recent study contacted an extended research on FTO 
localization and its function in different cell lines identifying that in HeLa cells FTO is 
predominantly located in the cell nucleus while in HEK293 cells FTO is located both in the 
cytoplasm and cell nucleus91. In addition, FTO demethylation activity is more profound in HeLa 
cells in comparison with HEK 293 and 3T3-L1 cell lines. This indicates that differences in m6A 
distribution among different cell types are expected due to the different FTO localization and 
function 91.   
TNT-seq in conjunction with BrU pulse-chase reveals that the signature of early m6A 
deposition at splice junctions and within introns is associated with distinct RNA processing 
kinetics2. Interestingly, m6A position is a feature within many that improves the prediction power 
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of a logistic regression model fit contributing to fast or slow splicing (Figure 11). More 
specifically, the 5´and 3´ SJ 100nt m6A signal contributes to fast splicing in very similar way as 
the 5´ and 3´ SJs score. This means that the lack of strong sequence consensus at SJs of many 
introns may be compensated by the presence of m6A that could eventually attract splicing factors 
to exert their function. In other words, m6A could potentially act as a splicing enhancer of splicing 
inhibitor either from via attracting proteins or repelling them92. In addition, m6A presence 
changes the structure of RNA locally that could either reveal or hide protein binding sites93. Long 
introns together with intronic methylation contribute to slow processing and alternative splicing. 
More than 50% of the nascent m6A peaks are found in introns. This is not surprising since introns 
are much longer than exons and have relatively increased possibility to be bound by 
methyltransferases. Bartosovic et al.,42 showed that FTO, an m6A demethylase, binds mostly to 
introns, mediating m6A removal. FTO knockout causes alternative splicing events with a 
preference for exon-skipping, suggesting that demethylation of mRNA transcripts promotes exon-
inclusion under normal conditions42. Taken together, these findings suggest that intronic m6A 
marks that are not targeted or not yet removed by FTO mediate exon skipping while introns 
involved in constitutive splicing show no enrichment in the m6A signal and most probably are 
targets of FTO42. In mRNAs, m6A is enriched in the consensus DRACH motif; however not all 
DRACH motifs are methylated, indicating that the presence of the sequence motif alone is not 
enough to drive m6A deposition. FTO CLIP data show no significant enrichment of the DRACH 
motif42 leading us to hypothesize that early m6A intronic deposition is mostly in non-DRACH 
sequences where FTO can detect and eventually remove the m6A marks.  
Using de novo motif analysis, we identified three motifs sharing a SAG core with a higher 
positional enrichment compared to the consensus DRACH motif. Interestingly, the three novel de 
novo found motifs that are enriched in our m6A peaks resemble binding sites of SRSF splicing 
factors known as splicing enhancers or splicing inhibitors87. m6A position alone, or the altered 
RNA structure after m6A deposition could favor the binding of an SRSF splicing inhibitor and/or 
could repel the binding of an SRSF splicing enhancer and vice versa. On the other hand, if m6A 
favors the binding of both splicing inhibitors and splicing enhancers then the stoichiometry and 
binding affinity of each protein could play an important role for the final outcome. Recently, Xiao 
et al. demonstrated that the m6A reader YTHDC1 recruits SRSF3 while competing away SRSF10 
and binds to m6A sites promoting exon inclusion69. In the absence of YTHDC1 and SRSF3, 
SRSF10 has the availability to bind to free m6A sites independently, promoting exon skipping. 
This is also supported by a previous study from Ajiro et al., 2016 showing that SRSF3 knockdown 
in U2OS cells causes exon skipping events87. When we calculated the average SRSF10/SRSF3 
ratio per nucleotide position for the three subgroups fast, medium, slow and constitutive versus 
alternatively spliced transcripts we observed a similar distribution and profile to the m6A signal, 
confirming the competitive binding of SRSF10 versus SRSF3 to m6A regions. 
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A key method in our study was qTNTchase-seq that enabled us to directly compare the 
processing of individual transcripts in the methylated versus unmethylated state. Our results 
show that on transcript level m6A directly controls splicing kinetics irrespectively of the 
underlying transcript sequence. A gene can be transcribed several times generating transcripts 
with identical sequence (transcript copies). We show that transcript copies can have different 
methylation levels. We cannot exclude the possibility that within the transcript copies m6A can 
be found in different positions. With TNT-seq we identified the positions that the transcripts 
could potentially be methylated, within methylated transcript copies though, some of the 
potential sites could be methylated or not. Furthermore, our analysis on the splicing kinetics for 
each individual transcript is the average of the splicing kinetics from all the transcripts produced 
from the same gene. Different RNA molecules with identical sequences could have different 
methylation status and if they are methylated then the position of the m6A can be also different. 
It still remains unknown what drives the methyltransferase complex to RNA substrate selection 
and further investigation is necessary to answer this key question. m6A could potentially 
facilitate as a labelling signal that could be recognized by m6A reader proteins to sort 
methylated transcripts into a fast-track processing. In a next step the position of m6A together 
with the presence of splicing inhibitors or enhancers direct the kinetics of the introns within a 
transcript.  
qTNTchase-seq enabled us to have a genome-wide quantitative measurement of how many 
transcripts copies of a particular gene are m6A modified (m6A level) of nascent RNA ( BrU-
Chase seq 0 min) and also 30 minutes chased nascent RNA (BrU-Chase Seq 30 min).  The m6A 
levels at 0 time point as well as 30 minutes chase follow almost the same normal distribution 
implicating that the overall m6A modification levels on transcripts remain the same for at least 
~45 minutes after transcription. This finding does not exclude that demethylation occurs within 
the ~45 minutes since even if a transcript is demethylated but leaves only one m6A modification 
it would be pulled down and end up in the eluate contributing to the reads that increase the 
assessed transcript m6A level. qTNTchase-seq (as well as the previously published method80 of 
Molinie et al., 2016) does not employ an initial RNA fragmentation step, hence this approach 
allows for quantitative measurement of the m6A-methylated transcripts per gene; however, it 
does not provide the precise positional information about where exactly the m6A modification 
is deposited along the transcript. Furthermore, we were not able to draw any conclusions 
regarding different m6A levels (i.e. high, medium and low m6A level, representing the 
differential relative fraction of methylated transcript copies versus non-methylated transcript 
copies within each cluster) and splicing efficiency. The splicing efficiency is measured either 
locally per splicing junction, or at transcript level. High m6A level at transcript level can 
inevitably also include transcripts that are methylated within the introns, which in turn 
correlates with slow processing. qTNTchase-seq does not distinguish whether the transcripts are 
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methylated within the introns or at SJs. Thus, within the methylated transcripts one could find 
all three cases of processing. 
Our analysis proposes a role of m6A in splicing that contradicts the finding of Ke et al., 
suggesting no role for m6A in splicing44. Ke et al., examined the RNA splicing profiles in steady 
state poly-A isolated RNA in control and METTL3 knock-out ESC mouse cells and found that 
all m6A-containing constitutive exons were spliced quantitatively the same in both conditions. In 
our functional analysis in HEK293 cells we identified a significant difference of the METTL3 
knock down effect between the highly methylated SJs from compare to low and medium. Even 
though we observed an overall increase of SED upon METTL3 knock down, when focusing on 
the fast-processed introns we identified that only highly methylated ones showed significantly 
decreased SED. The slow-processed introns did not show any effect upon METTL3 knock down 
suggesting that another methyltrasferase is responsible for the intronic methylation of slow 
processed genes, or that m6A has relatively low impact on slow processing kinetics. METTL16 
is a promising candidate to test since its m6A marks do not occur within the DGACH sequence 
motif and they are rather found in introns94.  
The lack of a method to deplete m6A alone and not the methyltransferase make it difficult 
to conclude whether the effects upon METTL3 depletion are m6A driven.  METTL3 physically 
interacts with RNA pol II and it has been proposed that transcription rates influence the 
engagement of the methyltransferase complex with slow transcription or RNA pol II pausing to 
increase the probability of METTL3 binding46. The crosstalk between slow or paused RNA pol 
II and METTL3 engagement could explain the overall splicing efficiency increase independent 
from m6A presence. Further investigation on the role of METTL3 and m6A on transcription 
elongation rates and pausing are needed to draw legitimate conclusions. 
Our findings are in the same line with a previous study that describes m6A methylation as a 
mark for selective nuclear processing providing evidence for an m6A dependent mRNA 
metabolism59. Roundtree et al, showed that the knock-down of YTHDC1, results in defective 
nuclear export of target mRNAs, and does so in an m6A-dependent, splicing-independent 
manner59. This agrees with the tight biochemical coupling of mRNA splicing and export, that is 
reflected by the dual roles observed for similar adaptor proteins, particularly those of the SRSFs 
family. One of the pioneered studies in 2012 from Dominissini et al., had already observed a 
relationship with alternative splicing events and m6A deposition43. Recently, two studies71,95 in 
Drosophila melanogaster revealed methylation-dependent changes in splicing modulating sex 
determination. Mettl16 was found to methylate the 3´UTR of MAT2A leading to the splicing of 
retained introns and production of more MAT2A96. In spermatogenic cells in murine testes 
Alkbh5 knock-out enhanced splicing events97. Our findings moved a step forward our 
understanding of the RNA splicing code, coupling RNA methylation with the direction and 
kinetics of splicing. 
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5. Conclusions-Outlook 
____________________________________________________________  
 We are still far from fully understanding the “epitranscriptome code”. Many other RNA 
modifications could contribute to the regulation of RNA processing, thus different combinations 
of RNA modifications could drive the final outcome.  Our study shows that the crucial role of 
m6A on splicing efficiency dynamics as well as on alternative splicing is positional dependent. 
m6A deposited in intronic regions sorts transcripts to a slow-track processing pathway and is 
associated with alternative splicing while, m6A found in splice-junction exonic boundaries, sorts 
transcripts to a fast-track processing pathway and constitutive splicing 
The technological advances have been beneficial in biological studies aiming to elucidate 
the complexity of cellular RNA. However, future experiments are needed to further our 
understanding in RNA modifications and RNA processing. It has been shown that METTL3 
methylates pri-miRNAs, facilitating the recognition and processing by DGCR8. METTL3 
depletion resulted in global reduction of mature miRNAs and a concomitant accumulation of 
unprocessed pri-miRNAs98. However, TNT-Seq did not detect any m6A peaks on the 38 pri-
miRNAs that we studied. It would be interesting to perform an additional analysis to correlate 
the pri-miRNA processing efficiency in the methylated and unmethylated state transcriptome-
wide using qTNT-chase Seq data.  
Furthermore, it is necessary to identify the underlying mechanism driving the fast track 
RNA splicing. Many m6A readers could be the proteins factors behind this mechanism. YTH-
protein family, HNRNPG, HNRNPC and splicing factors SRSFs are potential candidates that 
could be functionally tested via siRNAs or auxin-inducible degradation system following 
qTNT-chase Seq.  Recently, a method was developed called RNA interactome using click 
chemistry (RICK) that can be used to capture proteins bound to nascent RNA99. Combining our 
nascent RNA m6A data set together with RICK on m6A depleted conditions we could identify 
new m6A readers that bind specifically on nascent RNA with high affinity on m6A.  
We are still far from understanding the m6A role on single molecule RNAs. With the 
establishment of TNT-Seq we identified possible m6A locations on nascent transcripts. 
However, is not clear whether all the transcript copies acquire m6A on the identified locations. 
Single molecule m6A detection techniques are needed to be developed in order to dig deeper 
into m6A role on single RNA molecules.  
The field is still in the early stage of discoveries. It remains a mystery how the selectivity, 
both at the transcript level and at specific modification sites, is achieved, and how this is coupled 
with transcriptional events. In addition, we still do not know how effector proteins, m6A readers, 
are regulated. Importantly, beyond simple cell lines, we have to dive into complex in vivo 
biological systems and further reveal functional relevance, as well as the potential implications 
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for human diseases. Our knowledge of this field is a continuously evolving process and new 
discoveries, mechanistic investigations, and in-depth discussions will further broaden our views. 
 
6. Summary in English and German 
____________________________________________________ 
 The current thesis studies the RNA processing dynamics in a high-resolution time scale 
manner. The method used, called BrU Chase Seq (described in detail in ref.4) , determined the 
processing kinetics of pri-miRNAs within intact cells over time using a pulse-chase approach to 
obtain nascent RNA within a 1-hour window after transcription. Further analysis showed that pri-
miRNAs exhibit different processing kinetics ranging from fast over intermediate to slow 
processing. In addition, polycistronic pri-miRNAs show differential processing. The first part of 
the thesis is part a study published in3. 
The second part of the thesis describes for the first time the role of m6A RNA modification 
impact on RNA splicing kinetics. Two techniques have been developed namely TNT-Seq and 
qTNT-Chase Seq. These techniques provide the first time-resolved high-resolution assessment of 
m6A on nascent RNA transcripts and unveil its importance for the control of RNA splicing 
kinetics. More specifically, the early co-transcriptional m6A deposition near splice junctions 
promotes fast splicing, while m6A modifications in introns are associated with long, slowly 
processed introns and alternative splicing events. In conclusion, the early m6A deposition 
specifies the fate of transcripts regarding splicing kinetics and alternative splicing. The second 
part of the thesis was published in2. 
Die vorliegende Arbeit untersucht die RNA-Prozessierungsdynamik auf einer 
hochaufgelösten Zeitskala. Durch die verwendete Methode, der sogenannten BrU Chase Seq 
(detailliert in ref.4 beschrieben), konnte die Prozessierungskinetik von pri-miRNAs in intakten 
Zellen in ihrem Zeitverlauf unter Verwendung eines Puls-Chase-Ansatzes, um innerhalb eines 1-
stündigen Zeitraumes nach der Transkription nascest RNA zu erhalten bestimmt werden. Weitere 
Analysen zeigten, dass pri-miRNAs unterschiedliche Prozesskinetiken aufweisen, von schnell 
über intermediär bis langsam. Darüber hinaus zeigen polycistronische Pri-miRNAs eine 
differentielle Prozessierung. Der erste Teil dieser Arbeit ist Teil einer in 3 veröffentlichten Studie. 
Der zweite Teil dieser Arbeit beschreibt zum ersten Mal die Rolle der m6A-RNA-
Modifikation für die Kinetik der RNA-Splicing Es wurden zwei Techniken entwickelt, die TNT-
Seq und die qTNT-Chase Seq. Diese Techniken bieten die erste zeitaufgelöste Bewertung von 
m6A an aufkommenden RNA-Transkripten mit hoher Auflösung und zeigen deren Bedeutung für 
die Kontrolle der RNA-Splicing-Kinetik auf. Genauer gesagt, die frühe co-transkriptionelle m6A-
Anlagerung in der Nähe von Spleißverbindungen fördert ein schnelles Spleißen, während m6A-
Modifikationen in Intronsmit langen, langsam verarbeiteten Introns und alternativen 
Spleißereignissen verbunden sind. Zusammenfassend lässt sich sagen, dass die frühe Anlagerung 
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von m6A das Schicksal von Transkripten in Bezug auf die Kinetik von Spleißen und alternatives 
Spleißen bestimmt. Der zweite Teil der Dissertation wurde in2 veröffentlicht. 
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SUMMARY
Splicing efficiency varies among transcripts, and
tight control of splicing kinetics is crucial for coordi-
nated gene expression. N-6-methyladenosine (m6A)
is the most abundant RNA modification and is
involved in regulation of RNA biogenesis and func-
tion. The impact ofm6A on regulation of RNA splicing
kinetics is unknown. Here, we provide a time-
resolved high-resolution assessment of m6A on
nascent RNA transcripts and unveil its importance
for the control of RNA splicing kinetics. We find that
early co-transcriptional m6A deposition near splice
junctions promotes fast splicing, while m6A modifi-
cations in introns are associated with long, slowly
processed introns and alternative splicing events.
In conclusion, we show that early m6A deposition
specifies the fate of transcripts regarding splicing ki-
netics and alternative splicing.
INTRODUCTION
The RNA nucleotide code is supplemented by more than a hun-
dred chemical modifications, greatly extending the functionality
and information content of RNA (Fu et al., 2014; Harcourt et al.,
2017). N-6-methyladenosine (m6A) is deposited by a protein
complex consisting of the methyltransferase-like 3 and 14
(METTL3 and METTL14), Wilms’ tumor 1-associating protein
(WTAP), and the Virilizer homolog (KIAA1429) (Liu et al., 2014;
Ping et al., 2014; Schwartz et al., 2014). Early studies have
demonstrated that adenosine methylation frequently occurs
within a subset of RRA*CH consensus sites (R, purine; A*, meth-
ylatable A; H, non-guanine base) (Narayan and Rottman, 1988).
Fat mass and obesity associated (FTO) and AlkB homolog 5
(ALKBH5) are m6A demethylases, adding dynamics to the func-
tion of m6A in RNA biogenesis (Jia et al., 2011; Zheng et al.,
2013). m6A is involved in a number of RNA processes, including
splicing, RNA degradation, and translation (Bartosovic et al.,
2017; Dominissini et al., 2012; Ke et al., 2017; Meyer et al.,
2015; Slobodin et al., 2017; Wang et al., 2014; Xiao et al.,
2016). These pathways are mediated in part by members of
the YTH-domain protein family calledm6A readers, which recog-
nize and bind specifically to sequences marked with m6A (Xiao
et al., 2016; Xu et al., 2014). The presence of m6A can affect
the RNA structure and increase the accessibility of the adjacent
RNA sequence for the heterogeneous nuclear ribonucleopro-
teins HNRNPG and HNRNPC, with an effect on splicing (Liu
et al., 2015, 2017). Because of the challenging nature of
addressing the impact of m6A on splicing at the mature RNA
level, the direct role of m6A on splicing dynamics has not
been investigated so far. Here, using TNT-seq (transient N-6-
methyladenosine transcriptome sequencing) and qTNTchase-
seq (quantitative TNT pulse-chase sequencing), we show that
m6A modifications deposited early and co-transcriptionally
near splice junctions (SJs) positively affect RNA splicing kinetics.
Furthermore, we show that intronic m6A deposition is connected
with slow processing kinetics and alternative splicing events.
Our results strongly support a scenario where nascent m6A
deposition is functionally involved in regulating splicing effi-
ciency (SE) and alternative splicing.
RESULTS
TNT-Seq Reveals m6A Deposition on Newly
Transcribed RNA
We developed TNT-seq to identify and study m6A on nascent
RNA. In brief, bromouridine (BrU)-labeled RNAwas isolated, frag-
mented, and purified with a BrU-specific antibody. Subsequently,
m6A methylated fragments were isolated using an m6A-specific
antibody.The labeledRNA (BrU-RNA input) and them6A-enriched
RNA fragments (BrU-m6A-RNA IP eluate) were sequenced
to identify positions of m6A on nascent RNA (Figure S1A). We
find enrichment of m6A around start and stop codons as well as
at 50 and 30 SJs reproducibly across independent replicates
(Figure S1B), demonstrating a robust experimental pipeline
(genome-wide m6A signal correlation = 0.58). The majority
(57%) of earlym6Apeaks (Experimental Procedures) residewithin
introns, whereas 22% reside in coding sequences (CDSs), 5%are
in 50 UTRs, and 9% are in 30 UTRs (Figure S1C). To compare m6A
peak distribution in newly transcribed RNA with steady-state
mRNA, we reanalyzed published m6A-sequencing (m6A-seq)
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data (Schwartz et al., 2014) and calledm6A peaks using the same
pipeline. The majority of steady-state mRNAm6A peaks reside in
theCDS (52%), 30UTR(28%),and50UTR (12%),whileonlyaminor
fraction (4%) is intronic (FigureS1D). Almost half of theCDS-asso-
ciated nascent m6A peaks reside within 100 nt upstream of the
50 SJ, and approximately one-fifth are within 100 nt downstream
of the 30 SJ (Figure S1C). For steady-state mRNA, only 17% and
11%of theCDSpeaksarewithin the respective intervals, suggest-
ing a transient functional roleof earlym6Adeposition (FigureS1D).
By normalizing the number of m6A peaks to the length of the
analyzed intervals and the respective input read coverage, we
find that the early m6A deposition is enriched within 100 nt of the
50 SJ exonic boundary (Figure 1A). To validate the earlym6A sites,
weassessed thepresenceof them6AconsensusDRACHmotif by
performing de novomotif search with HOMER (Heinz et al., 2010)
in the regions ±150 nt around the peak summit of the top scoring
peaks (score >20, n = 5,651) or in randomly generated 300-nt
genomic intervals.WefindaDGACHmotifwithapositional enrich-
ment around the peak summit, in particular for exonic peaks (Fig-
ure 1B). We also identify three additional motifs sharing an SAG
core,with a strongpositional enrichment around the peak summit,
especially for intronic peaks (Figure 1B). Early m6A deposition is
predominant at and in close proximity to SJs (Figures 1C and
1D). In contrast, the picture is inversed around start and stop co-
dons, with a relatively greater number of peaks in steady-state
mRNA (Figures 1E and 1F). This finding led us to examinewhether
early m6A deposition in close proximity to SJs has an impact on
splicing of RNA.
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Figure 1. TNT-Seq Reveals m6A Deposition on Newly Transcribed RNA
(A) Distribution of the normalized number of m6A peaks to the length of the analyzed intervals and the respective input read coverage for TNT-seq and mRNA
m6A-seq data.
(B) Number of motif occurrences (sum) at nucleotide positions around the m6A peak summit of the top scoring 5,651 exonic peaks, intronic peaks, or random
intervals. The line represents loess curve fitting (local polynomial regression), with the 95% confidence interval shaded gray.
(C–F) Distribution (frequency) of the distance of m6A peak summits to the closest given anchor point 50 SJ (C), 30 SJ (D), start codon (E), and stop codon (F) for
nascent RNA (TNT-seq) and mRNA (m6A-seq; Schwartz et al., 2014).
See also Figure S1.
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m6A Signatures Separate Distinct Intron Classes
To determine the splicing kinetics of newly transcribed RNA, we
used BrU-Chase Seq as described previously (Louloupi et al.,
2017; Paulsen et al., 2013). Cells were labeled with a 15-min
BrU pulse and chased for 0, 15, 30, and 60 min, followed by
RNA purification. To determine SE across all time points, we
calculated the splicing index value q (Mukherjee et al., 2017)
(Figure 2A), yielding 13,532 introns with an extracted q value
ranging from 0 (unspliced) to 1 (fully spliced). The degree of
splicing at 0 min, representing nascent RNA, is lower compared
to steady-state chromatin-associated RNA (Conrad et al.,
2014), indicating that nascent pre-mRNA is more efficiently
captured by our approach than by chromatin fractionation (Fig-
ure 2B). Using k-means clustering, we called three clusters of
distinct SE dynamics (SED; Experimental Procedures) repre-
senting 4,882 fast-, 5,702 medium-, and 2,948 slow-processed
introns (Figures 2C–2F). Three representative cases are de-
picted in Figure 2E. We plotted the average m6A signal per
nucleotide position around 50 and 30 SJs (Figures 2G–2H) and
within length-binned introns for the three groups (Figure S2B).
Strikingly, we find that fast-processed introns show greater
m6A deposition at SJs, with an overall positive relationship be-
tween m6A deposited at 50 and 30 SJ exonic boundaries and
processing efficiency (Figures 2G–2J and Figures S2A–S2C).
By plotting the average frequency of m6A peak summits per
nucleotide position (instead of the average m6A signal) for the
three subgroups, we reach the same conclusion (Figures
S2D–S2F). In contrast, slowly processed introns are associated
with increased m6A deposition within the intron (Figures S2B
and S2E). To address whether the position of an intron affects
m6A signal and SE, we looked at the average m6A signal per
nucleotide position around the 50 and 30 SJs of only the first
and last introns (of transcripts with at least four exons), showing
that the effect is independent of the position of the intron
(Figures S2G–S2J).
m6A Deposition at Nascent RNA Predicts SED
To further investigate the impact of m6A deposition on nascent
RNA in shaping the SED, we used a logistic regression model
fit to predict fast- versus slow-processed introns (Figures 2I
and 2J). We find that inclusion of the m6A at SJs as an additional
parameter improves thepredictive power of themodel (Figure 2I),
with the m6A contribution in predicting fast processing being
comparable to other previously shown features, such as the 50
and 30 SJ sequence scores and distance to transcription
start site (TSS) and transcription end site (TES) (Figure 2J) (Mu-
kherjee et al., 2017). Intron length and internal m6A signal are
significantly associated with slow processing (Figure 2J). To
complement this analysis, we applied linear regression to predict
SED as a continuous value (Figure S3). Again, introducing the
m6A at SJs improves the correlation between predicted and
measured SED (Figures S3A–S3C), further confirming the impact
of early m6A deposition on RNA processing.
Intronic m6A Deposition Associates with Alternative
Splicing
We assessed alternative versus constitutive splicing (by extract-
ing the c value), as slow pre-mRNA processing has been shown
to favor the occurrence of alternative splicing (Mukherjee et al.,
2017) (Figure 2A). Alternative splicing events are significantly en-
riched in slow processed introns (odds ratio, 3.84; Fisher’s exact
test p value < 2.2e-16) (Figure 3A). Additionally, intronic m6A
peaks are associated with upstream or downstream exon skip-
ping approximately two times more often than expected by
random chance (odds ratio, 1.7; Fisher’s exact test p value <
2.2e-16), suggesting that intronic m6A deposition is involved in
alternative splicing. In concurrence, the average m6A signal is
greater along alternative versus constitutively spliced introns
and the average m6A signal is greater at constitutive versus
alternatively spliced SJ exonic boundaries (Figures 3B–3D).
The overall intronic m6A, along with the intron length, are signif-
icant contributors in determining alternative splicing (Figure 3E).
In contrast, m6A at SJ exonic boundaries and strong splice site
consensus sequences (SJ score) ensure constitutive splicing
(Figure 3E). Inclusion of m6A improves the predictive power of
the model fit of constitutive versus alternative splicing
(Figure 3F).
Splicing Factors Coincide with m6A Deposition
To investigate how m6A functionality in splicing is mediated, we
analyzed available crosslinking immunoprecipitation sequencing
(CLIP-seq) data for SRSF factors with an established role in
splicing (Xiao et al., 2016). We find that both SRSF3 and
SRSF10 show a high probability to have an m6A peak summit
in close proximity (<250 nt) (Figures S4A and S4B), with
SRSF10 showing relatively greater affinity (Figure S4C). The
SAGmotif core that we identify in early m6A peaks is reminiscent
of the SRSF binding site motifs (Ajiro et al., 2016; Xiao et al.,
2016). In addition, both SRSF3 and SFRF10 have been shown
to bind near m6A, and while SRSF3 binding is augmented
through interaction with YTHDC1, SRSF10 can bind indepen-
dently to m6A modified regions (Xiao et al., 2016). In agreement
with this observation, we find that the ratio of SRSF10/SRSF3
binding is greater at the SJ exonic boundaries for fast-processed
introns and internally along within slow-processed introns (Fig-
ures S4D–S4F), in concordance with the respective relative
enrichment of early m6A deposition (Figures 2G, 2H, and S2).
The average ratio of SRSF10/SRSF3 binding clearly separates
alternative and constitutive spliced introns (Figures S4G–S4I),
most prominently along length-binned introns (Figure S4H).
This result is in agreement with the observation that alternative
splicing can be antagonistically regulated by SRSF10 versus
SRSF3 binding (Xiao et al., 2016). These results suggest that
m6A could play a role in shaping the final outcome of splicing
through the recruitment of splicing factors with varying m6A
affinities.
qTNTchase-Seq Identifies m6A-Marked Fast-Track
RNAs
To separate direct m6A-mediated effects on RNA processing
from sequence specific ones, we used qTNTchase-seq. Here,
BrU-labeled RNA was isolated at 0 and 30 min chase and m6A
transcripts were isolated with an m6A-specific antibody without
fragmentation. Both supernatant (m6A negative transcripts) and
eluate (m6A positive transcripts) were sequenced for each time
point to obtain quantitative information, and we calculated the
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Figure 2. m6A Deposition at Nascent RNA Determines SED
(A) Definition of q and c value.
(B) Cumulative distribution of the SE index from chromatin-associated RNA-seq (Conrad et al., 2014), BrU-Chase Seq (0, 15, 30, and 60 min).
(C) Violin plot representing the density of the SE index (q value) distribution with embedded box and whisker plots for introns grouped on the basis of differential
splicing kinetics.
(D) Heatmap showing the k-means clustering results (with k = 3) of the splicing SE index (q value) of the 13,532 filtered introns measured for the BrU-Chase time
points. Introns are clustered into fast, medium, and slow processed.
(E) UCSC genome browser views of representative cases of introns from each of the three clustering groups.
(F) Boxplot showing distribution of the SED for the fast-, medium-, and slow-processed intron groups.
(G and H) Average m6A signal per nucleotide position in a ±500-nt window around 50 SJs (G) and 30 SJs (H) of the filtered introns.
(I) Average receiver-operating characteristic (ROC) curve for discrimination of fast versus slow introns, including all characteristics and excluding m6A. The
respective area under the curve (AUC number) is indicated.
(J) Contribution of each feature to themodel fit of fast versus slow processing calculated as the coefficients from the binary logistic regression with the associated
estimated significance (log10 p value). The features with p value < 0.001 are colored red.
See also Figures S2–S4.
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m6A level per transcript (Molinie et al., 2016). On a transcrip-
tome-wide scale, we observe a strong concordance of m6A
levels between biological replicates, both for the top 25% ex-
pressed transcripts and for all transcripts with non-zero
coverage (0 min: Pearson r = 0.89, p value < 2.2e-16; 30 min:
Pearson r = 0.91, p value < 2.2e-16). The m6A levels do not
significantly differ between 0 and 30 min chase, indicating that
the overall m6A modification levels of transcripts remain the
same for at least 45 min after transcription (not shown). To
follow SE, we extracted the transcript splicing index from m6A-
positive and m6A-negative transcripts at 0 and 30 min chase.
Within the pulse, corresponding to a 15-minwindow of transcrip-
tion, m6A-positive transcripts show significantly higher SE than
m6A-negative transcripts (Figure 4A). In addition, by measuring
SED at the transcript level, we find that the m6A-positive tran-
scripts show significantly greater processing than their m6A-
negative counterparts (two tailed paired t test p value < 2.2e-
16) (Figure 4B). Importantly, processing appears significantly
enhanced for the m6A fraction of individual transcripts; 76%
show gain of SED in the m6A fraction, revealing a direct and
sequence-independent impact of m6A on processing kinetics
(Figure 4C). We further examined the SE locally for the 13,532
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Figure 3. Intronic m6A Deposition Associates with Alternative Splicing
(A) Violin plots showing density of the distribution (with embedded box-and-whiskers plots) of q value for introns classified as either constitutive or alternative
spliced extracted from all pulse-chase time points.
(B–D) Average m6A signal per nucleotide position in a ±500-nt window around the 50 SJ (B) and 30 SJ (D) and per bin (C) of 6,742 introns with length 1,000–10,000
nt. The average m6A signal is extracted separately for the two subgroups (constitutive and alternative). The lines represent LOESS curve fitting (local polynomial
regression), with the 95% confidence interval shaded gray.
(E) The contribution of each feature to alternative versus constitutive splicing, calculated as the coefficients of the binary logistic regression fit with associated
estimated significance (log10 p value). Features with p < 0.001 are colored red.
(F) Average ROC for the logistic regression prediction of the alternative versus constitutive splicing using all features, with and without m6A data. The respective
AUC number is indicated.
See also Figure S4.
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filtered introns.We find that14%have significantly higher SE in
the m6A-positive transcripts and show a 1.26-fold enrichment
over random chance to have an m6A peak in the 50 SJ 250-nt
exonic boundary (odds ratio, 1.265; Fisher’s exact test p value =
0.0006745). In addition, individual intron loci show on average
significantly higher SED in the m6A-positive versus m6A-nega-
tive transcripts (two-tailed paired t test p value < 2.2e-16)
(Figure 4D).
We used qPCR to analyze the splicing kinetics of four candi-
date SJs that have at least one m6A peak (±250 nt). Strikingly,
at time point 0, m6A-positive transcripts show higher SE than
the m6A-negative transcripts (Figures 4E and 4F). We confirmed
this result with semiquantitative PCR (Figures 4G and 4H).
Nascent m6A Effects Are METTL3 Dependent
To provide a direct link between RNA splicing kinetics and m6A
deposition at SJs, we assessed the splicing kinetics after
METTL3 knockdown (METTL3 KD) (60 min chase) (Figure 4I).
The intron dataset was divided into three equal-size quantiles
based on the m6A signal at 50 and 30 SJs (50 and 30 SJ 100-nt
exonic intervals), and the SED was calculated. We plotted the
log2 ratio of SED for METTL3 KD to control for introns with
low, medium, and high m6A signal (Figure 4J). For introns with
high m6A signal on both 50 and 30 SJs, we observe a decreased
SED upon METTL3 KD for approximately half of the entries (log2
SED ratio METTL3 KD/control < 0) (Figure 4J). For introns
with low and medium m6A signal (log2 SED ratio METTL3 KD/
control > 0), we observe an increased SED (Figure 4J). The differ-
ence in the SED ratio (log2 METTL3 KD/control) of high m6A
signal compared to low or medium is significant for both com-
parisons (t test p value < 2.2e-16). We then focused on fast-pro-
cessed introns and plotted them6A signal (sum of 50 SJ and 30 SJ
100-nt exonic area) for those that show reduced SED upon
METTL3 KD versus the rest (Figure 4K). We find that the
METTL3-affected introns have significantly higher m6A at the
50 and 30 SJ exonic boundaries. This verifies that the 50 and 30
SJ exonic methylation promotes fast splicing kinetics, as also
shown by the logistic regression model fit (Figure 2J). We see
the same but less pronounced tendency for the slow-processed
introns (Figure 4L). qPCR analysis of SED for four candidates
confirms the transcriptome-wide data (Figures 4M–4P).
DISCUSSION
We identify an enrichment of m6A deposition near the 50 SJs of
nascent RNA transcripts, andwe show that early m6A deposition
is associated with distinct RNA processing kinetics. Most impor-
tantly, we compare the processing of individual m6A-positive
transcripts versus their m6A-negative counterparts, demon-
strating that m6A directly controls splicing kinetics irrespectively
of the underlying transcript sequence. Our findings suggest that
m6A serves as a labeling signal that could be recognized bym6A
reader proteins to destine methylated transcripts for specific
splicing kinetics. This is in agreement with a study describing
m6A methylation as a mark for selective nuclear processing,
providing evidence for an m6A-dependent mRNA metabolism
(Roundtree et al., 2017).
Our findings furthermore reveal that intronic m6A peaks are
enriched in introns involved in alternative splicing. The m6A de-
methylase FTO binds mostly to introns and mediate removal of
m6A. Knockout of FTO causes alternative splicing events with
a preference for exon skipping, suggesting that demethylation
of mRNA transcripts promotes exon inclusion under normal con-
ditions (Bartosovic et al., 2017). Taken together, these findings
suggest that intronic m6A marks that are not targeted or not
yet removed by FTO mediate exon skipping, while introns
involved in constitutive splicing show no enrichment in the
m6A signal and most probably are targets of FTO (Bartosovic
et al., 2017). In mRNAs, m6A is enriched in the consensus
DRACH motif; however, not all DRACH motifs are methylated,
indicating that the presence of the sequence motif alone is not
enough to drive m6A deposition. FTO CLIP data show no signif-
icant enrichment of the DRACH motif (Bartosovic et al., 2017),
leading us to hypothesize that early intronic m6A deposition is
mostly in non-DRACH sequences where FTO can detect and
eventually remove the m6A marks.
Recently, the m6A reader YTHDC1 was shown to recruit
SRSF3 while competing away SRSF10. YTHDC1 binds m6A
sites and promote exon inclusion (Xiao et al., 2016). In the
absence of YTHDC1 and SRSF3, SRSF10 has the availability
to bind to free m6A sites independently, promoting exon skip-
ping. SRSF3 knockdown in U2OS cells has also been shown
to cause exon-skipping events (Ajiro et al., 2016). Using de
Figure 4. qTNTchase-Seq Identifies m6A-Marked Fast-Track RNAs
(A) Boxplot representing the overall SE of methylated (m6A positive) versus non-methylated (m6A negative) transcripts at time points 0 and 30 min.
(B) Violin plots showing distribution of the transcript SED in m6A-positive and m6A-negative fractions (two-tailed Student’s t test p value < 2.2e-16).
(C) Cumulative distribution of transcript SED differences between the methylated and unmethylated state (DSED = SED m6A positive  SED m6A negative).
(D) Boxplot displaying SED per intron in m6A-positive and m6A-negative transcripts (two-tailed paired t test p value < 2.2e-16).
(E and F) qPCR analysis of the local intronic SE of methylated versus non-methylated transcripts for 0 min (E) and 30 min (F).
(G and H) UCSC genome browser tracks of qTNTchase-seq data for LMAN2 (G) and C8orf33 (H) representing the transcript regions used for the qRT-PCR
analysis. Normalized read coverage (reads per million of total number of mapped reads) tracks for input (blue), supernatant m6A negative (gray), and eluate m6A
positive (pink). The upper overlay track represents the TNT-seq with purple for input and green for IP; black rectangles above represent the called m6A peaks.
Below tracks for each sample are agarose gels depicting semiquantitative PCR of input, m6A-positive, and m6A-negative samples for 0 and 30 min.
(I) Western blot for METTL3 KD.
(J) Log2 ratio of SED in METTL3 KD to control for introns with low, medium, and high m6A signal at both 50 and 30 SJs (100-nt exonic area).
(K) m6A signal at both 50 SJs and 30 SJs (100 nt exonic area) for the fast-processed introns that show reduced SED in the METTL3 KD condition versus the rest
(two-tailed Student’s t test p value < 2.2e-16).
(L) m6A signal at both 50 SJs and 30 SJs (100 nt exonic area) for the slow-processed introns that show reduced SED in the METTL3 KD condition versus the rest
(two-tailed Student’s t test p value < 2.2e-16).
(M–P) qPCR analysis of SED for fast- (M and N), medium- (O), and slow-processed (P) introns (error bars show SD, n = 2 biological replicates (*p < 0.05 and **p <
0.01, two-tailed Student’s t test).
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novomotif analysis, we identify three additional motifs sharing a
SAG core reminiscent of the SRSF binding site consensus, sug-
gesting that m6A could be involved in recruiting splicing factors
to control SE and alternative splicing.
The lack of strong consensus sequences at SJs of many in-
trons may be compensated by the presence of m6A that could
eventually attract splicing factors to exert their function. Our
study shows that the crucial role of m6A on SED as well as on
alternative splicing is position dependent. m6A deposited in in-
tronic regions sort transcripts to a slow-track processing
pathway and is associated with alternative splicing while m6A
deposited at exonic boundaries of SJs sort transcripts to a
fast-track processing pathway and constitutive splicing.
EXPERIMENTAL PROCEDURES
Cell Culture and BrU-Chase Sequencing
HEK293 cells were cultured in DMEMgrowthmedium supplementedwith 10%
fetal bovine serum (FBS) under normal growth conditions (37C and 5% CO2).
Cells were 70%–80% confluent before addition of BrU. BrU (5-bromouridine,
Santa Cruz Biotechnology catalog number CAS 957-75-5) was added to a final
concentration of 2 mM to the medium and cells were incubated at normal
growth conditions for 15 min. Cells were washed three times in PBS and either
collected directly or chased in conditional medium supplemented with 20 mM
uridine (Sigma catalog number U3750-25G) for 15, 30, and 60 min. RNA was
purified using TRIzol following the manufacturer’s instructions.
TNT-Seq
For one TNT-seq sample,25 150-mmplates were used for BrU labeling. RNA
was labeled and isolated as described above. RNA concentration was
adjusted to 2 mg/mL with nuclease-free water. 18 mL RNA was added to a
thin-walled 200-ml PCR tube following the addition of 2 mL 10X fragmentation
mixture (100 mM Tris-HCl [pH 7.4] and 100 mM ZnCl2 in nuclease-free water).
Distribution of post-fragmentation size (100 nt) was analyzed using an Agilent
2100 Bioanalyzer with an Agilent RNA 6000 Pico kit according to the manufac-
turer’s instructions. 400–600 mg fragmented BrU-labeled total RNA was used
for each BrU immunoprecipitation (IP). BrU-RNA isolation was performed as
described above. 5 mg BrU fragmented RNA was used as input for the m6A-
IP buffer. An RNA-antibody-beads mixture was incubated for 2 hr at 4C
with gentle rotation in a final volume of 0.8 mL in protein low-binding tubes.
Three washing steps were performed with 1X m6A-IPbuffer (1st and 2nd
wash) and high-salt m6A-IP buffer (500 mM NaCl, 0.1% Igepal CA-6300,
10 mM Tris-HCl [pH 7.5]) (3rd wash). At the last wash, the protein low-binding
tubes were replaced with DNA LoBind tubes. For elution, 80 mL elution buffer
(1X m6A-IP buffer + 6.7 mM m6A nucleotides) was added directly on the
beads, and the tubes were incubated for 1 hr with continuous shaking
(1,100 rpm) at 4C. After the second round of elution, RNAwas ethanol precip-
itated and resuspended in 15 mL RNase-free water, and the RNA concentration
was measured using the Qubit RNA HS Assay Kit as per the manufacturer’s
instructions.
siRNA Transfection
HEK293 cells were transfected with four different siRNAs targeting METTL3
transcript (Table S1) using HiPerFect Transfection Reagent from QIAGEN. In
brief, reverse transfection was performed using 1 3 106 cells for a single
100-mmplate. Cells were seeded in a final 4mL volume ofmediumwithout an-
tibiotics. 12 mL transfection reagent together with siRNAs (25 nM final concen-
tration) was incubated at room temperature (RT) in 1 mL Opti-MEM I Reduced
Serum Medium after mixing for 20 min. The transfection complexes were
added drop-wise into the plate. 16 hr after transfection, 5 mL cell culture me-
dium was added to each plate. A second transfection was performed 24 hr af-
ter the first transfection. After 40 hr, 5 mL cell culture medium was added to
each plate. Knockdown efficiency was analyzed with western blot (anti-
METTL3 polyclonal antibody; Protein Tech catalog number 15073-1-AP).
BrU-Chase Seq samples were prepared 72 hr after the first transfection. The
experiments were performed in duplicate.
RNA Sequencing and Data Analysis
For the BrU- Chase Seq, the library preparation was done using the TrueSeq
Stranded Total RNA Kit (Illumina). Sequencing was performed on an Illumina
HiSeq 2500 instrument to obtain 200 million reads per sample. For the
TNT-Seq, 100 ng of Input BrU-labeled fragmented RNA and 100 ng of TNT-
IP eluate RNA were subjected to library preparation following the TruSeq
Stranded mRNA Library Preparation Kit instructions with some modifications.
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The accession numbers for the BrU-chase-seq, TNT-seq, qTNTchase-seq,
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Supplemental Experimental Procedures 
Cell culture and BrU-chase Seq. 
HEK293 cells were cultured in DMEM growth-medium supplemented with 10% Fetal Bovine 
Serum (FBS) under normal growth conditions (37°C and 5% CO2). The day before 
bromouridine (BrU) labelling ~2.0 x 10^6 cells were seeded in 100 mm plates with 10ml 
media, one plate for each time point. Cells were 70-80% confluent before the addition 
bromouridine (BrU). BrU (-5-Bromouridine cat.no. CAS 957-75-5 Santa Cruz 
Biotechnology) was added to a final concentration of 2 mM to the media and cells were 
incubated at normal growth conditions for 15 min (pulse). Cells were washed three times in 
PBS and either collected directly (0 min chase time point) or chased in conditional media 
supplemented with 20 mM uridine (Sigma cat.no U3750-25G) for 15, 30 and 60 min. RNA 
was purified using TRIzol following manufacturer’s instructions.  
In the next step we followed the protocol of (Paulsen et al., 2013) with some modifications. 
40ul of anti of anti-mouse IgG magnetic Dynabeads (Invitrogen) were transferred to a 1.5ml 
microfuge Protein Low binding tube and washed 3 times with BrU-IP 1X buffer (0.1% BSA 
in RNAse free PBS). After the final wash, the beads were resuspended in BrU-IP 1X buffer 
supplemented with SUPERase• In™ RNase Inhibitor 1:2000 together with BrdU antibody 
(5μg of antibody per 100 μg RNA). Antibody-beads mixture was incubated for 1 hour at room 
temperature with gentle rotation following 3 washes with 1X BrU-IP. 150 μg RNA was used 
for each BrU-IP and heated up for 4 min at 65°C prior to IP. The same amount of unlabeled 
total RNA was used as a negative control. 5X BrU-IP (0.5% BSA 5X PBS supplemented with 
SUPERase• In™ RNase Inhibitor 1:2000) was added to the RNA to a final concertation of 
1X. RNA-antibody-beads mixture was incubated for 90 min at room temperature with gentle 
rotation in a final volume of 800 ul. The beads were washed three times with 800 ul 1X BrU-
IP at room temperature. For all wash steps, with the exception of the elution step, the beads 
were washed for 5 min rotating then placed on a magnetic rack and the wash buffers were 
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discarded. At the last wash the Protein low binding tubes were replaced with DNA LoBind 
tubes. For elution 200 ul of Elution buffer (0.1% BSA and 25 mM bromouridine in PBS) were 
added directly on the beads and the tubes were incubated for 60 min with continuous shaking 
(1100 rpm) at 4 °C. The supernatant (eluate w/o beads) was transferred to a new tube and 
RNA was precipitated by adding 1/10 volumes of 3M sodium acetate (pH 5.2) and 3-4 
volumes of 100% ethanol. RNA was allowed to precipitate at −80 °C overnight. RNA pellet 
was washed twice with 75% ethanol and resuspended in RNase-free water. RNA quality was 
analyzed using Agilent 2100 Bioanalyzer with an Agilent RNA 6000 Pico kit according to the 
manufacturer’s instructions.  
 
TNT-seq 
For one TNT-seq sample ~25 150 mm plates were used for BrU labelling. RNA was 
metabolically labelled with BrU for 15 min and RNA was isolated as described above. RNA 
concentration was adjusted to 2 μg/ul with nuclease free water. 18 ul of RNA was added to 
thin-walled 200µl PCR tube following addition of 2 ul of 10X fragmentation mixture 
(containing 800 µl of RNase-free water, 100 µl of 1M Tris-HCl pH 7.4 and 100 µl 1M of 
ZnCl2). After vortex and quick spinning the tubes were incubated in 94 °C for 3.5 min in a 
preheated thermal cycler block with the heated lid closed. Tubes were quickly removed from 
the thermocycler and placed on ice following addition of 2 µl of 0.5 M EDTA. After vortex 
and quick spin the RNA was collected in a tube to continue with for RNA precipitation using 
1/10 volumes of 3 M sodium acetate (pH 5.2), 3-4 volumes of 100% ethanol. RNA was 
allowed to precipitate at −80 °C overnight. The following day tubes were centrifuged at full 
speed for 30 min at 4 °C. RNA pellet was washed twice with 75% ethanol and resuspended in 
400-500 ul of RNase-free water. Validation of post fragmentation size (~100 nt) distribution 
was analyzed using Agilent 2100 Bioanalyzer with an Agilent RNA 6000 Pico kit according 
to the manufacturer’s instructions. 400-600 ug fragmented BrU labeled total RNA was used 
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for each BrU-IP. BrU-RNA isolation was performed as described above. The BrU-IP 
recovery was approximately 0.09-0.16% of input. 4.5 ug of BrU fragmented RNA was used 
as input for the m6A immunoprecipitation. 40 ul of Dynabeads® Protein A  (Invitrogen) per 
sample was transferred to a 1.5 ml microfuge Protein LoBind tube and washed 3 times with 
1X m6A-IP (500 mM NaCl, 0.1% NP-40, 10 mM Tris-HCl, pH 7.5). After final wash the 
beads were resuspended in 800 ul 1X m6A-IP buffer supplemented with SUPERase• In™ 
RNase Inhibitor 1:1000. 1ug of affinity purified anti-m6A polyclonal antibody (Synaptic 
Systems) per 2.5 ug BrU-RNA was added to the beads and incubated for 60 min at room 
temperature with gentle rotation. As a negative control, we used Dynabeads® Protein A 
magnetic beads bound to an irrelevant IgG. Beads were washed 3 times with m6A-IP 1X 
buffer for 5 min on the rotator. 5 ug of BrU Fragmented RNA was used as input. RNA was 
heated up for 4 min at 65 °C. 5X m6A-IP buffer (50 mM Tris-HCl, 750 mM NaCl and 0.5% 
(vol/vol) Igepal CA-6300 supplemented with SUPERase• In™ RNase Inhibitor) was added to 
have the RNA in 1X m6A-IP buffer. RNA-antibody-beads mixture was incubated for 2 hours 
at 4°C with gentle rotation in a final volume of 0.8ml in Protein low binding tubes. Three 
washing steps followed using m6A-IP 1X buffer (1
st
 and 2
nd
 wash) and high salt m6A-IP 
buffer (500 mM NaCl, 0.1% Igepal CA-6300, 10 mM Tris-HCl, pH 7.5) (3
rd 
wash). For all 
wash steps, with the exception of the elution step, the beads were washed for 5 min then 
placed on a magnet and the wash buffers were discarded. At the last wash the Protein low 
binding tubes were replaced with DNA LoBind tubes. For elution 80 ul of Elution buffer (1X 
m6A-IP buffer + 6.7 mM m6A nucleotides) were added directly on the beads and the tubes 
were incubated for 1 hour with continuous shaking (1100 rpm) at 4 °C. The beads were spun 
down and the supernatant was transferred to a clean tube. After the second round of elution 
the eluted RNA was precipitated using ethanol precipitation as described above. RNA pellet 
was resuspended in 15 ul RNase-free water and using Qubit® RNA HS Assay Kit we 
measured the RNA concentration following manufacturer’s instructions. 
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qTNTchase-seq, qPCR, RT-PCR. 
RNA was metabolically labelled with BrU for 15 min and chased for 30 min as described 
above. RNA was purified using TRIzol following manufacturer’s instructions. 200 ug total 
BrU labeled RNA was used as Input for the BrU-RNA isolation. After the elution step (200 ul 
of 0.1% BSA and 25mM bromouridine in PBS) we added 50 ul of 5X m6A-IP buffer. 4 ug 
(1 ug ab per 500 ng RNA) m6A ab were coupled to 40 ul Dynabeads® Protein A as described 
above, resuspended in 550 ul m6A-IP 1X buffer and added to the RNA mixture. RNA-
antibody-beads mixture was incubated for 60 min at room temperature with gentle rotation. 
The supernatant was kept and RNA was isolated with TRIzol. The beads were washed 3 times 
for 5 min at RT (twice with low salt m6A-IP 1X buffer and last wash high salt m6A-IP 1X 
buffer). We eluted the RNA captured by m6A antibody by competition as described in TNT-
Seq section. cDNA synthesis was performed using the same amount of RNA (10-20 ng) from 
all fractions (Input BrU-RNA 0 min, Input BrU-RNA 30 min chase, Supernatant m6A-
negative 0 min, Supernatant m6A-negative 30 min chase, IP m6A-positive 0 min, IP m6A-
positive 30 min chase). RT-PCR was performed using Q5 Hot Start High-Fidelity DNA 
Polymerase New England Biolabs with initial denaturation 98 °C 30s, then 32 cycles of 98 °C 
10 s, 58 °C 20 s and 72 °C 55 s and final extension 72 °C 2 min. PCR products were resolved 
on agarose gel. Spike-in controls were in vitro transcribed using T7 RNA Polymerase 
Invitrogen following manufactures instructions. For the methylated transcripts N6-methyl-
ATP (TriLink) was used in a ratio 4:1 to ATP in the in vitro transcription reaction. GFP and 
Luciferase sequences were used as template for the RNA transcription. For each qTNTchase-
seq sample before m6A IP, in vitro–transcribed transcripts with and without m6A 
modification were mixed into the samples as spike-in controls at the indicated percentage of 
m6A-modified to m6A-unmodified transcript (Molinie et al., 2016). For all samples after 
BrU-IP but before m6A-IP we added 2.5x10
7
 copies from each spike including: 0% GFP and 
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20% luciferase. Before the library preparation for sequencing, 1 ul of 1:2000 dilution of the 
universal ERCC spike-in control A (Invitrogen) was added to each fraction (100 ng). 
 
siRNA transfection 
HEK293 cells were transfected with four different siRNAs targeting METTL3 transcript (see 
Supplemetary Table 1) using HiPerFect Transfection Reagent from QIAGEN. In brief, 
reverse transfection was performed using 1 x 10
6
 cells for a single 100 mm plate. Cells were 
seeded in a final 4 ml final volume of media without antibiotics. 12 ul of transfection reagent 
together with siRNAs (25 nM final concentration) were incubated at room temperature in 
1 ml Opti-MEM
TM
 I Reduced Serum Media after mixing for 20 min. The transfection 
complexes were added dropwise into the plate. 16 hours after transfection 5 ml of cell culture 
media were added to each plate. 24 hours after the first transfection we performed a second hit 
using the same amount of transfection reagent and siRNAs as the first round. 40 hours after 
the first transfection 5 ml of cell culture media were added to each plate. We analyzed knock 
down efficiency with western blot (anti-METTL3 Polyclonal antibody, protein tech 
Catalog.number: 15073-1-AP) and continued with BrU-Chase Seq 72 hours after the first hit. 
The experiment was performed in duplicates. 
 
Transcript m6A-level and splicing index 
The m6A level per transcript from the qTNTchase-seq experiment were calculated as 
described in (Molinie et al., 2016). The ratio of the RNA abundance for each transcript 
between the eluate and the supernatant was represented by the ratio of the overlapping strand-
specific RNA read counts normalized to the ratio of the reads of the ERCC RNAs. We used 
the log2-transformed read counts of ERCC RNAs to fit a linear regression model, computing 
the eluate ERCC reads as a function of the supernatant ERCC reads with a coefficient of 1 
(not shown). The log2 ratio between ERCC eluate counts and supernatant counts was 
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indicated by the intercept of the regression formula. Only the ERCC RNAs with at least 100 
read counts were used in this pipeline.  
M6A level = E/(E+S*2^intercept) 
Eluate read counts (E), supernatant read counts (S), and the intercept of ERCC regression 
(intercept) 
We assessed the splicing efficiency per transcript as the ratio of the overlapping strand-
specific split reads (extracted by using bedtools coverage –s –F 1.0) to all (split + non-split) 
reads covering the transcript. 
 
Quantitative real-time PCR 
RNA was reverse transcribed using the GoScript reverse transcription Promega A500. cDNA 
was quantified on an 7900HT Fast real time PCR system (Applied Biosystems) using the Go 
Taq qPCR Master Mix Promega (A6001). The PCR was carried out using a standard protocol 
with melting curve. Primers for unspliced RNA transcripts were design to span exon – intron 
5’ splice junction and exon – exon boundaries for spliced RNA transcripts. Splicing efficiency 
(SE) was determined by the ration of 2^-CTspliced / (2^-CTspliced+2^-CTunspliced) for each 
timepoint. SED was determined by the ration of SED = 1/ ((1- SE0 min) * (1- SE60 min)) 
 
RNA sequencing and data analysis  
For the BrU-Chase Seq, the library preparation was performed using the TrueSeq Stranded 
Total RNA Kit (Illumina). Sequencing was performed on an Illumina HiSeq 2500 instrument 
to obtain around 200M reads per sample. For the TNT-Seq, 100 ng of Input BrU-labeled 
fragmented RNA and 100 ng of TNT-IP eluate RNA were subjected to library preparation 
following the TruSeq Stranded mRNA Library Preparation Kit instructions with some 
modifications. The protocol started from the first strand synthesis step and 3X Clean-NA-
Beads beads volume was used for the buffer exchange to include shorter RNA fragments. 
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Mapping of strand-specific reads to GRC37 genome assembly (hg19) was done using STAR 
(Dobin et al., 2013) and only uniquely mapped reads were kept for further downstream 
analyses. To extract read coverage per nucleotide position across the genome the strand-
specific bed files were sorted by chromosome and start coordinate and converted into wig 
files with bedtools genomecov using –scale to normalize for library size. To assess the 
genome-wide correlation of the m6A signal from replicates, the ratio of normalized read 
counts per nucleotide position of IP to Eluate, rendering the m6A signal, was converted to 
bigWig using wigToBigWig (UCSC) and then bigWigCorrelate (UCSC) was used. To extract 
the m6A signal per nucleotide position in given intervals, the depth at each nucleotide 
position of the examined intervals (e.g. within +/- 500 bp windows around anchor points) was 
extracted using bedtools coverage –d –s from the m6A Input and the respective m6A IP, and 
then the ratio m6A IP/Input multiplied by (total number of mapped reads in the Input/ total 
number of mapped reads in the IP) was calculated. Then the average m6A signal was 
extracted at each nucleotide position from all examined entries. 
 
m6A peak calling 
We called m6A peaks based on a previously published pipeline (Ke et al., 2015; Ke et al., 
2017). We first divided the genome into 20 bp non-overlapping bins with bedtools 
windowMaker and extracted the strand-specific read coverage from m6A Input and IP for all 
bins using bedtools coverageBed –s. Fisher’s exact test p-value was extracted from the matrix 
(bin Input read counts, bin IP read counts, total number of mapped reads in the Input, total 
number of mapped reads in the IP) and adjusted by the Benjamini and Hochberg method to 
determine the false discovery rate (FDR). Only windows with a p-adjusted < 0.05 in all three 
replicates and fold enrichment (score) minimum four in at least two out of the three replicates 
were kept as significant. Adjacent significant bins were merged using bedtools mergeBed into 
broader peaks (finally 95 % of the peaks were in the range 20-100 nt long). In the case of 
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broad peaks, the peak summit is the midpoint of the 20 nt window with the maximum score, 
or the midpoint of the interval of merged adjacent bins sharing same maximum score within 
the same peak. In a few cases, a broad peak was assigned more than one summits if it 
contained non-adjacent windows sharing the same maximum score, finally yielding 58102 
m6A peaks and 58311 peak summits. Custom scripts were written in awk programming 
language.  
 
De novo motif search 
De novo motif search was run using HOMER (Heinz et al., 2010) within +/-150 nt intervals 
around the peak summit of 5651 best scoring exonic m6A peaks (minimum fold enrichment 
20) and the same number of top best intronic peaks. Control sequences were generated from 
the respective input sequences with the scrambleFasta.pl script. Then, de novo motif search 
was run with ‘findsMotifs.pl input_sequences.fa fasta –basic –rna –len 6,7,8 –fasta 
scrambled_sequences’. The results were inspected in terms of enrichment, significance and 
the presence of common consensus sequences, with the four motifs displayed in Figure 1B 
being the most represented. Those were used to scan the input sequences for the presence of 
match occurrences using the ‘dna-pattern’ search tool from the RSAT suite (Medina-Rivera et 
al., 2015) with parameters ‘search given strand only, prevent overlapping matches, origin-
start, return flanking nucleotide positions 2’. Motif search was also performed in the same 
number of random genomic intervals as a control, generated with bedtools (–length 300 –
number 5651). The matches were aligned and the logo was generated with WebLogo3 
(Crooks et al., 2004) . 
 
Splicing kinetics and predictive models 
To assess splicing efficiency we extracted the splicing index value as in (Mukherjee et al., 
2017).  equals to the ratio of the split reads mapping to the 5’ and 3’ SJ of an intron divided 
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to the sum of split plus non-split reads (schematic representation in Figure 2A). The  value 
(representing Splicing Efficiency, SE) was extracted from all pulse-chase time points, for 
13,532 introns with at least five reads coverage at both 5’ and 3’ SJ, and used in k-means 
clustering with k = 3 to call three groups of distinct splicing efficiency (fast, medium and 
slow) (Supplementary Figure 2B). The Splicing Efficiency Dynamics metric was calculated 
as SED = 1/ ((1.001-  0 min) * (1.001-  60 min)) (plotted in the log scale for the three 
groups in Figure 2F). To assess constitutive versus alternative splicing we extracted the  
value as in (Mukherjee et al., 2017).  is the ratio of constitutive split reads assigned to a 
given intron’s 5’ and 3’ SJ to all split reads (i.e. split reads from the given intron 5’ SJ to any 
downstream 3’SJ and from the intron’s 3’ SJ to any upstream 5’ SJ, as depicted in Figure 2A). 
Therefore  is in the range 0 to 1 with 1 meaning 100 % constitutive splicing. We then used 
the  value extracted from the pulse-chase time point 60 min (closer to steady-state) to 
perform k-means clustering with k = 2 and define two clusters of introns, constitutive (n = 
11836, minimum  0.5294) and alternative (n = 1696, maximum  0.5278). In the case of 
introns classified as alternative spliced ( < 0.5278) upstream or downstream exon skipping 
takes place.  
The following features were used in logistic and linear regression models to predict splicing 
efficiency kinetics and alternative versus constitutive splicing: 
The 5’ and 3’ splice site underlying sequence scores extracted using MaxEntScan 
(http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html); distance of the 5’ SJ to 
the annotated transcript first start site (TSS) and of the 3’ SJ to the last end site (TES); 
expression calculated as coverage (reads per kb) from the m6A Input RNA-seq (15 min BrU 
pulse) for the whole transcript interval where the intron belongs to; intron length; intron 
overall m6A signal extracted as the strand-specific m6A IP read coverage divided to m6A 
Input read coverage, normalized by (total number of mapped m6A Input reads * total number 
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of mapped m6A IP reads); m6A signal calculated the same way at the 5’ SJ 100 nt exonic 
boundary, 5’ SJ 100 nt intronic boundary, 3’ SJ 100 nt exonic boundary and 3’ SJ 100 nt 
intronic boundary.  
To predict fast versus slow or alternative versus constitutive splicing, logistic regression was 
performed with R function glm (family = binomial) (all parameters apart from the sequence 
scores were first log scale transformed and all were then standardized). To evaluate the fitting 
of the model and assess discrimination, the Receiver Operating Characteristic Curve (ROC) 
and the area under the curve (AUC) were calculated with the R package ROCR (Sing et al., 
2005). Linear regression to predict splicing efficiency using the continuous value  (in the 
range 0 to 1) was performed with R function lm().  
 
CLIP data analysis 
We used CLIP data for SRF3 and SRSF10 from (Xiao et al., 2016)(GEO GSE71096). To 
calculate the relative SRSF10/SRSF3 binding per nucleotide position, we used the ModeScore 
column from the GEO submitted PARalyzer output file, which is the score of the highest 
signal divided to the sum value (signal+backround) and ranges from 0.5 to 1. We first 
extracted the coverage for each SRSF per nucleotide position in the +/-500 nt window around 
5’ or 3’ SJ, or per bin for the length-binned introns (introns with length 1000-10,000 nt, 
binned into 1000 non-overlapping windows), by using bedtools coverage –s –d. Nucleotide 
positions with overlapping CLIP binding sites were assigned the cluster’s score (ModeScore 
column) whereas nucleotide positions with no CLIP data overlap were assigned a pseudo-
score 0.1. We then computed the ratio SRFS10/SRSF3 per nucleotide position or per bin of 
all analyzed loci and the metagene analysis extracting the average ratio SRFS10/SRSF3 per 
nucleotide position or per bin was run separately for each of the subgroups fast/medium/slow 
or constitutive/alternative. 
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Table 1: Primer Sequences. All the primers and siRNAs where purchased from 
Integrated DNA Technology, Inc. (IDT)  
 
RT-PCR and qPCR primers 
NAME Sequence 
CDKN1B unspliced Forward AATAAGGAAGCGACCTGCAA 
CDKN1B unspliced Reverse atacgccgaaaagcaagcta 
CDKN1B spliced Forward AATAAGGAAGCGACCTGCAA 
CDKN1B spliced Reverse GGGGAACCGTCTGAAACAT 
LMAN2 unspliced Forward GTGACTGCGGATATAACTGACG 
LMAN2 unspliced Reverse ctcgccctcactcttcactc 
LMAN2 spliced Forward GTGACTGCGGATATAACTGACG 
LMAN2 spliced Reverse ATAGTGCTGCCCTGGAAGTC 
NASP unspliced Forward CATGGAGTCCACAGCCACT 
NASP unspliced Reverse tgccttaagctttccacagtc 
NASP spliced Forward CATGGAGTCCACAGCCACT 
NASP spliced Reverse GCAGATGTAGAAGGAGCAGGA 
ARF4 unspliced Forward CCTCCCTCTTCTCCCGACT 
ARF4 unspliced Reverse attgtggagaccctgccttt 
ARF4 spliced Forward CCTCCCTCTTCTCCCGACT 
ARF4 spliced Reverse TTGTCTTGCCAGCAGCATC 
C8orf33 Forward TAAGAAGAAAACGCGGAACAGG 
C8orf33 Reverse GGTGGGTTTCTGCCTCTTGA 
MSN unspliced Forward TCAAGAAGCTGAAGAGGCCA 
MSN unspliced Reverse agttcccataatcccagccc 
MSN spliced Reverse CTGTCAGCTCTGCCATTTCC 
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SPTBN1 unspliced Forward CTGGATGAGCGAGCAGGAG 
SPTBN1 unspliced Reverse aagtgtgcccagggtttgaa 
SPTBN1 spliced Revers GCATAGTCCTCCACAGCTTGT 
NOL7 unspliced Forward TCCTGAAGGAGAAGAGGAAGC 
NOL7 unspliced Forward aattctccctgagccgagtt 
NOL7 spliced Forward AACGCTCCTGAAGGAGAAGA 
NOL7 spliced Reverse TCCAAAATAGTGTCTGGAAGGA 
 
 
 
NAME siRNA Target Sequence 5’→3’ 
Mettl3-1 5’-ACUGCUCUUUCCUUAAUA 
5’-AAACAUGUAUUAAGGAAA 
Mettl3-2 5’-CCAACAGUCCACUAAGGA 
5’-CUGUUGUUCCUUAGUGGA 
Mettl3-3 5’-AGGCAAGGAACAAUCCAU 
5’-UUCAACAAUGGAUUGUUC 
Mettl3-4 5’-AGCCAAGGAACAAUCCAU 
5’-UUCAACAAUGGAUUGUUC 
Control NCI  IDT controls 
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Figure S1;Related to Figure 1:m6A signal and motif analysis 
(A) Schematic representation of the TNT-seq protocol. (B) The average m6A signal per nucleotide position 
around start and stop codons, 5’ and 3’ SJs is shown. (C-D) m6A peak distribution in (C) newly transcribed 
RNA and (D) mRNA(Schwartz et al., 2014)
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Figure S2; Related to Figure 2: M6A signal and splicing kinetics (A-C) Average m6A signal per nucleotide 
position in the window +/-500 nt around (A) 5΄SJ and (C) 3΄SJ and (B) internally per bin for 6742 introns (with 
length 1000-10000 nt), for fast, medium and slow processed introns. (D-F) Average frequency of m6A peak 
summits per nucleotide position in the window +/- 500 nt around (D) 5’ SJ, (F) 3’ SJ of all 13,532 filtered introns, 
and (E) per bin of 6722 introns 1000-10000 nt long, extracted separately for fast, medium, slow subgroups. 
The lines represent loess curve fitting (local polynomial regression) with the 95% confidence interval grey 
shaded.(G-J) Average m6A signal per nucleotide position around the 5’ and 3’ SJs of only the first and last 
introns.n = number of introns
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Figure S3; Related to Figure 2:Prediction of SED in a linear regression model
(A-C) Prediction of Splicing Efficiency Dynamics (SED) (as a continuous value) from (A) all features excluding 
m6A data (B) including m6A data using linear regression. The line indicates the linear regression fit between
predicted and measured SED and the correlation value (R) with the associated significance is indicated.
(C) Plot depicting the contribution of each feature to the linear fit predicting SED. (D) Boxplots depicting the 
distribution of intron length for the three groups Fast (pink), Medium (Green) and Slow (blue) introns.
(E) Boxplots depicting the distribution of the m6A signal in the 100 nt exonic window boundary adjacent to the 
5’SJ, for the three groups. (F) Boxplots depicting the distribution of the m6A signal in the 100 nt exonic window 
boundary adjacent to the 3’SJ, for the three groups.
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Figure S4; Related to Figure 2 and 3: Splicing factors coincide with m6A deposition 
(A-C) Distribution of the interdistances of factor binding sites to closest m6A peak summit for (A) SRSF3
(B) SRSF10 and (C) overlap. As a control, distance from the midpoint of the respectively same number of 
randomly generated genomic intervals is also plotted.  (D-F) Distribution of the average ratio SRSF10/SRSF3 
binding, extracted separately for the three subgroups fast/medium/slow per nucleotide position in the window
 +/-500 nt around the 5’SJ (D) and 3’SJ (F), or per bin (E) for 6,742 length-binned introns (with a length 
1,000-10,000 nt). (G-I) Same analysis as in (D-F) but comparing the average SRSF10/SRSF3 ratio for the two 
subgroups constitutive versus alternative.
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